Protein,Protein_definition,Trait_category,Trait,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X1050.Time spend outdoors in summer,45733,0.0523433553141744,0.0486772443328338,-0.0430640435781798,0.147750754206529,0.282246058473306
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X1060.Time spent outdoors in winter,42509,0.0942241762063092,0.0550831158723759,-0.0137387309035475,0.202187083316166,0.0871755166148305
PON1,Serum paraoxonase/arylesterase 1,Physical activities,X1070.Time spent watching television (TV),47095,0.0149132184243165,0.0492916455855713,-0.0816984069234032,0.111524843772036,0.762235122729082
PON1,Serum paraoxonase/arylesterase 1,Physical activities,X1080.Time spent using computer,42488,0.130767283169309,0.0522989622808473,0.0282613170988484,0.23327324923977,0.0124148172406841
PON1,Serum paraoxonase/arylesterase 1,Physical activities,X1090.Time spent driving,40220,0.163993128510961,0.0566872135635522,0.052886189926399,0.275100067095523,0.00382167552533177
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X1160.Sleep duration,48412,-0.057759010709797,0.0446864749808006,-0.145344501672166,0.0298264802525721,0.196183021420361
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120039#0.Location of pain during the past week_None of the given areas,32657,-0.00293853811819915,0.00961230605251487,-0.0217786579811283,0.01590158174473,0.759836380063608
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120039#1.Location of pain during the past week_Left shoulder,32657,-0.00780128037172932,0.00858195182123869,-0.0246219059413572,0.00901934519789852,0.363359224772364
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120039#10.Location of pain during the past week_Upper right leg,32657,-0.013701098308553,0.0101977312264951,-0.0336886515124834,0.00628645489537734,0.179133116237739
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120039#11.Location of pain during the past week_Lower left leg,32657,-0.0023813899663609,0.0103524179908493,-0.0226721292284255,0.0179093492957037,0.818072446870743
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120039#12.Location of pain during the past week_Lower right leg,32657,-0.0085857108599989,0.0105266109024819,-0.0292178682288635,0.0120464465088657,0.414741374066645
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120039#13.Location of pain during the past week_Left jaw pain,32657,-0.032474008655287,0.0202000487662967,-0.0720661042372285,0.0071180869266546,0.107956837806337
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120039#14.Location of pain during the past week_Right jaw pain,32657,-0.0417994663996652,0.0196935149381728,-0.080398755678484,-0.00320017712084648,0.0338257214741028
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120039#15.Location of pain during the past week_Chest pain,32657,-0.0347616490553041,0.0155995840884258,-0.0653368338686187,-0.00418646424198948,0.0258828273277465
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120039#16.Location of pain during the past week_Abdomen,32657,-0.0205627677479091,0.0111405331232638,-0.0423982126695061,0.001272677173688,0.0649628370477836
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120039#17.Location of pain during the past week_Neck pain,32657,-0.0156552778656717,0.00774699417283049,-0.0308393864444195,-0.00047116928692395,0.0433308572952371
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120039#18.Location of pain during the past week_Upper back,32657,-0.015295221980092,0.0107178218361769,-0.0363021527789988,0.00571170881881482,0.153594007545706
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120039#19.Location of pain during the past week_Lower back,32657,-0.00474827506251895,0.00656192443356513,-0.0176096469523066,0.00811309682726871,0.469325742563366
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120039#2.Location of pain during the past week_Right shoulder,32657,-0.0191219980959454,0.00814939323467901,-0.0350948088359162,-0.00314918735597453,0.0189777792444742
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120039#3.Location of pain during the past week_Upper left arm,32657,-0.0167640469902022,0.011687447612253,-0.0396714443102181,0.00614335032981377,0.15150669930914
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120039#4.Location of pain during the past week_Upper right arm,32657,-0.0222257660525161,0.010977775291954,-0.043742205624746,-0.00070932648028614,0.0429392626667654
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120039#5.Location of pain during the past week_Lower left arm,32657,0.0140366059529921,0.0153768116009146,-0.0161019447848005,0.0441751566907846,0.36135224379243
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120039#6.Location of pain during the past week_Lower right arm,32657,-0.0108751038685635,0.0145189000949931,-0.03933214805475,0.0175819403176229,0.453860092488635
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120039#7.Location of pain during the past week_Left hip,32657,-0.00248175889314436,0.00871556396907692,-0.0195642642725351,0.0146007464862464,0.77584268707382
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120039#8.Location of pain during the past week_Right hip,32657,-0.0110721531906438,0.00811013995437738,-0.0269680275012235,0.00482372111993587,0.172220261830972
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120039#9.Location of pain during the past week_Upper left leg,32657,-0.000382787542172474,0.0107868983627158,-0.0215251083330955,0.0207595332487506,0.971692801901684
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120040.Fatigue severity over the past week,32664,-0.278496773568359,0.0801356189735245,-0.435562586756468,-0.121430960380251,0.00051288472763925
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120041.Waking unrefreshed severity over the past week,32663,-0.22164949491882,0.0796963640459782,-0.377854368448937,-0.0654446213887031,0.00542861234649005
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120042.Cognitive symptoms severity over the past week,32661,-0.247253225115354,0.0851489095262188,-0.414145087786743,-0.0803613624439647,0.00369676779753768
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120098.Mobility problems today,32667,-0.277166377885443,0.0929261968563943,-0.459301723723975,-0.0950310320469098,0.00286603568876952
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120099.Self-care problems today,32667,-0.383662706903588,0.141609427692846,-0.661217185181566,-0.10610822862561,0.00675648106995769
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120100.Problems doing usual activities,32667,-0.127174329387899,0.0886812349721742,-0.30098954993336,0.0466408911575623,0.151592838605002
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120101.Pain or discomfort today,32667,-0.177865846875119,0.0801505507787344,-0.334960926401439,-0.0207707673487999,0.02650395690291
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120102.Anxiety or depression today,32667,-0.377078067692836,0.0920896446059187,-0.557573771120437,-0.196582364265236,4.26797861716501e-05
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120103.Scale to indicate how health is today,32628,0.0106713106434195,0.00282985235585389,0.0051248000259459,0.0162178212608932,0.000163755548855669
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120104.Little interest or pleasure in doing things over the last two weeks,32642,-0.423653466121903,0.0944946011211431,-0.608862884319344,-0.238444047924463,7.44764217272287e-06
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,"X120105.Feeling down, depressed, or hopeless over the last two weeks",32621,-0.342739605690283,0.0954726589531999,-0.529866017238555,-0.155613194142012,0.000332714433336743
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,"X120106.Trouble falling or staying asleep, or sleeping too much over the last two weeks",32650,-0.22355623493539,0.0793621782333902,-0.379106104272835,-0.0680063655979451,0.00486038470521592
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120107.Feeling tired or having little energy over the last two weeks,32650,-0.281022192884989,0.0817005928307631,-0.441155354833285,-0.120889030936694,0.000585348629271547
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120108.Poor appetite or overeating over the last two weeks,32653,-0.412041835311791,0.096133497442678,-0.600463490299439,-0.223620180324142,1.83882193960414e-05
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120109.Feeling bad about self over the last two weeks,32626,-0.123082861528407,0.101120953978348,-0.321279931325968,0.0751142082691544,0.223569160362121
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120110.Trouble concentrating over the last two weeks,32650,-0.280571243103837,0.103750281445548,-0.48392179473711,-0.0772206914705632,0.00685910758540536
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120111.Moving or speaking slower or faster than usual over the last two weeks,32641,-0.45485139556771,0.147428271592929,-0.74381080788985,-0.16589198324557,0.00204067251628973
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X120112.Thoughts of being better off dead or of hurting self over the last two weeks,32606,-0.422298296121338,0.203186808958109,-0.820544441679231,-0.0240521505634456,0.0377060808906157
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,"X120113.Level of difficultly depression has made to do work, take care of things at home, or get along with other people",30612,-0.229205062700261,0.103138913022719,-0.43135733222479,-0.0270527931757316,0.0262995854844661
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X1269.Exposure to tobacco smoke at home,46338,-0.0519848511106229,0.105227868841799,-0.258231474040549,0.154261771819303,0.621295809386328
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X1279.Exposure to tobacco smoke outside home,44708,0.0285596277016828,0.0700018395012372,-0.108643977720742,0.165763233124108,0.683289763080925
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X1289.Cooked vegetable intake,47929,0.167301536760152,0.04593089794748,0.0772769767830912,0.257326096737213,0.000270624330164141
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X1299.Salad  or  raw vegetable intake,47501,0.116852434653426,0.0499056625336161,0.0190373360875386,0.214667533219314,0.019216624417948
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X1309.Fresh fruit intake,47993,0.0521248982290153,0.047862449028626,-0.0416855018670916,0.145935298325122,0.276140239568493
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X1319.Dried fruit intake,46480,-0.0276852881997534,0.0482484940533842,-0.122252336544386,0.0668817601448796,0.566104766924182
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X134.Number of self-reported cancers,48668,-0.13220556471352,0.078309323107223,-0.285691838003677,0.021280708576637,0.0913764941478729
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X135.Number of self-reported non-cancer illnesses,48668,-0.298953367188572,0.0469634707181014,-0.391001769796051,-0.206904964581093,1.97939511189845e-10
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,"X136.Number of operations, self-reported",48668,-0.147984477039518,0.0470615364760371,-0.240225088532551,-0.0557438655464858,0.00166578306708145
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X137.Number of treatments or medications taken,48668,-0.237371561007076,0.0457852818298173,-0.327110713393518,-0.147632408620634,2.18391986383496e-07
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X1438.Bread intake,47835,-0.00720702772899862,0.00190170002179245,-0.0109343597717118,-0.00347969568628543,0.000151157948311664
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X1458.Cereal intake,47444,-0.123108710913684,0.0456708135862038,-0.212623505542644,-0.0335939162847251,0.00703201826553405
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X1488.Tea intake,47846,0.00121466326884481,0.00177854907282742,-0.00227129291389693,0.00470061945158654,0.494644071011923
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X1498.Coffee intake,46772,0.15087978310896,0.0466237378157305,0.0594972569901286,0.242262309227792,0.00121345111950964
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X1528.Water intake,47166,0.0525417923491795,0.0472400757510459,-0.0400487561228705,0.145132340821229,0.266051381773816
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X1568.Average weekly red wine intake,39223,0.28969895814282,0.057914417353685,0.176186700129597,0.403211216156042,5.7333455958653e-07
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X1578.Average weekly champagne plus white wine intake,39215,0.352761152150187,0.0583661240233089,0.238363549064502,0.467158755235872,1.54018435726302e-09
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X1588.Average weekly beer plus cider intake,39243,-0.00903508393144946,0.0739464609353261,-0.153970147364689,0.13589997950179,0.902754855429255
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X1598.Average weekly spirits intake,39182,0.0215946781113828,0.065614355268043,-0.107009458213981,0.150198814436747,0.742073336003465
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X1608.Average weekly fortified wine intake,39246,-0.0189251691421787,0.0986214695972528,-0.212223249552794,0.174372911268437,0.847825481672913
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X1737.Childhood sunburn occasions,42898,0.00533734564896553,0.0556255400906468,-0.103688712928702,0.114363404226633,0.92356025391638
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X1807.Father's age at death,42208,0.00341403081429902,0.00205043801268813,-0.000604827690569718,0.00743288931916777,0.095925385302543
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X1845.Mother's age,33846,0.00165650092997857,0.00461304586205568,-0.00738506895965057,0.0106980708196077,0.71953546116684
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X1873.Number of full brothers,48211,-0.138146596862811,0.0448035933255826,-0.225961639780953,-0.0503315539446688,0.00204896759432399
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X1883.Number of full sisters,48215,-0.127971635086688,0.0448507567554407,-0.215879118327352,-0.0400641518460242,0.00433082549383817
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X20015.Sitting height,48499,-0.00127264633605516,0.002349972248176,-0.00587859194248012,0.0033332992703698,0.588128029978613
PON1,Serum paraoxonase/arylesterase 1,Cognitive function,X20016.Fluid intelligence score,32317,0.00520021106298317,0.071667042507957,-0.135267192252613,0.145667614378579,0.942157545753352
PON1,Serum paraoxonase/arylesterase 1,Cognitive function,X20018.Prospective memory result,32616,-0.0162918640756277,0.0918587331203973,-0.196334980991606,0.163751252840351,0.859231742150056
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X20019.Speech-reception-threshold (SRT) estimate (left),32200,-0.00686996891532352,0.00333530544853676,-0.0134071675944556,-0.000332770236191462,0.039453666897195
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X20021.Speech-reception-threshold (SRT) estimate (right),32186,-0.00341774013895958,0.00333815575026548,-0.00996052540947992,0.00312504513156076,0.30594248608021
PON1,Serum paraoxonase/arylesterase 1,Cognitive function,X20023.Mean time to correctly identify matches,48382,-0.000954018345967889,0.00192626645157408,-0.00472950059105309,0.00282146389911731,0.620415425587484
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X20107#1.Illnesses of father_Heart disease,45833,0.000294673459079132,0.00395395738341836,-0.00745508301242085,0.00804442993057911,0.940592383630655
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X20107#10.Illnesses of father_Alzheimer's disease or dementia,45458,0.0104940132217784,0.00859932298993301,-0.00636065983849034,0.0273486862820471,0.222353439122797
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X20107#11.Illnesses of father_Parkinson's disease,45429,0.00502183837990277,0.0117291274750241,-0.0179672514711444,0.0280109282309499,0.66854553897908
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X20107#12.Illnesses of father_Severe depression,45446,-0.00656922560526121,0.00928201832748474,-0.0247619815271313,0.0116235303166089,0.479116599625013
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X20107#13.Illnesses of father_Prostate cancer,45452,-0.00180256252750877,0.00703239350206571,-0.0155860537915576,0.01198092873654,0.797704133312403
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X20107#2.Illnesses of father_Stroke,45589,0.0060923389482288,0.00515082522125647,-0.00400327848543389,0.0161879563818915,0.236906120834836
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X20107#3.Illnesses of father_Lung cancer,45537,-0.00207706903189319,0.00646511292179755,-0.0147486903586164,0.01059455229483,0.748006370875083
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X20107#4.Illnesses of father_Bowel cancer,45453,0.00757879051799042,0.00826041498937801,-0.00861162286119047,0.0237692038971713,0.358900121080143
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X20107#6.Illnesses of father_Chronic bronchitis or emphysema,45600,-0.00840407175328967,0.00578769065239311,-0.0197479454319802,0.00293980192540082,0.14649987000049
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X20107#8.Illnesses of father_High blood pressure,45638,-0.000420503688161119,0.00440777053122182,-0.00905973392935588,0.00821872655303364,0.923997589579236
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X20107#9.Illnesses of father_Diabetes,45523,-0.00944962244860177,0.0061365453093635,-0.0214772512549542,0.00257800635775069,0.12360148208877
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X20110#1.Illnesses of mother_Heart disease,47045,-0.000851116005453115,0.00436465116862103,-0.00940583229595034,0.00770360028504411,0.845393081858801
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X20110#10.Illnesses of mother_Alzheimer's disease or dementia,46927,-0.00240835008794631,0.00639683426171647,-0.0149461452409106,0.010129445065018,0.706555510288829
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X20110#11.Illnesses of mother_Parkinson's disease,46870,0.0177880549350496,0.0138427178340692,-0.00934367201972604,0.0449197818898253,0.198801457556009
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X20110#12.Illnesses of mother_Severe depression,46903,-0.00831937518713779,0.00688600057070859,-0.0218159363057266,0.00517718593145105,0.226999302371476
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X20110#2.Illnesses of mother_Stroke,46985,-0.01626336084875,0.00504500431144296,-0.0261515692991782,-0.00637515239832183,0.0012674526391504
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X20110#3.Illnesses of mother_Lung cancer,46884,-0.00132720977825901,0.00927699978095313,-0.0195101293489271,0.0168557097924091,0.886240488640718
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X20110#4.Illnesses of mother_Bowel cancer,46881,-0.00840726778529783,0.0082621438453001,-0.024601069722086,0.00778653415149036,0.308895738976265
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X20110#5.Illnesses of mother_Breast cancer,46910,0.00052217044987158,0.00653472361796839,-0.0122858878413465,0.0133302287410896,0.936311899159704
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X20110#6.Illnesses of mother_Chronic bronchitis or emphysema,46927,-0.0218897318445883,0.00735952512387915,-0.0363144010873914,-0.00746506260178517,0.00293931141592507
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X20110#8.Illnesses of mother_High blood pressure,47073,0.00255460819613082,0.00379675877710904,-0.0048870390070029,0.00999625539926454,0.50105645938456
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X20110#9.Illnesses of mother_Diabetes,46942,-0.0071911257836077,0.00596618277142899,-0.0188848440156085,0.00450259244839313,0.228094648809367
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X20111#1.Illnesses of siblings_Heart disease,43904,-0.0118813829354815,0.00627388141311736,-0.0241781905051915,0.000415424634228567,0.0582683677765977
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X20111#10.Illnesses of siblings_Alzheimer's disease or dementia,43773,-0.0379223187311203,0.0248255953988337,-0.0865804857128344,0.0107358482505937,0.126640868946888
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X20111#11.Illnesses of siblings_Parkinson's disease,43770,-0.00943839441674175,0.0260057617477688,-0.0604096874423686,0.0415328986088851,0.716657604537429
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X20111#12.Illnesses of siblings_Severe depression,43829,-0.00453149217095736,0.00701460613441622,-0.0182801201944132,0.00921713585249843,0.518281779356115
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X20111#13.Illnesses of siblings_Prostate cancer,43783,-0.0285993738574103,0.0148425856910427,-0.0576908418118539,0.000492094097033418,0.0540134901873755
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X20111#2.Illnesses of siblings_Stroke,43798,-0.00696467598689499,0.0106448170576091,-0.0278285174198088,0.0138991654460188,0.512940108956678
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X20111#3.Illnesses of siblings_Lung cancer,43778,0.0113910411619465,0.0129181754406643,-0.0139285827017556,0.0367106650256485,0.377904560919528
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X20111#4.Illnesses of siblings_Bowel cancer,43777,-0.0217768653274116,0.0127541703762979,-0.0467750392649554,0.00322130861013232,0.0877580432078132
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X20111#5.Illnesses of siblings_Breast cancer,43793,-0.00345536955124161,0.00916512743067767,-0.0214190193153698,0.0145082802128866,0.706168294033385
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X20111#6.Illnesses of siblings_Chronic bronchitis or emphysema,43799,-0.00854795590981258,0.011232233352288,-0.030563133280297,0.0134672214606718,0.44665430712607
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X20111#8.Illnesses of siblings_High blood pressure,43962,-0.0097018472482126,0.00462668565540408,-0.0187701511328046,-0.000633543363620611,0.0360123961349604
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X20111#9.Illnesses of siblings_Diabetes,43859,-0.0239979288791312,0.00663095012700291,-0.0369945911280569,-0.0110012666302055,0.000296405418828943
PON1,Serum paraoxonase/arylesterase 1,Mental health,X20127.Neuroticism score,43482,-0.000826746300417855,0.0468549981766357,-0.0926625427266238,0.0910090501257881,0.985922415219156
PON1,Serum paraoxonase/arylesterase 1,Cognitive function,X20128.Number of fluid intelligence questions attempted within time limit,32317,-0.0176658454369475,0.0729789191991227,-0.160704527067228,0.125372836193333,0.808733958701568
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X20161.Pack years of smoking,30946,-0.0142655197024587,0.00388041705704376,-0.0218711371342644,-0.00665990227065291,0.000238564511841202
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X20162.Pack years adult smoking as proportion of life span exposed to smoking,30946,-0.0142626245946061,0.00382514582047805,-0.0217599104027431,-0.00676533878646911,0.000194147710338052
PON1,Serum paraoxonase/arylesterase 1,Cognitive function,X20191.Fluid intelligence score,30491,0.115368193097148,0.0888243760000637,-0.0587275838629766,0.289463970057273,0.19405030803682
PON1,Serum paraoxonase/arylesterase 1,Cognitive function,X20192.Number of fluid intelligence questions attempted within time limit,30491,0.122199116504166,0.0910481835962905,-0.0562553233445632,0.300653556352896,0.17960220372877
PON1,Serum paraoxonase/arylesterase 1,Cognitive function,X20240.Maximum digits remembered correctly,29826,-0.0646975654283492,0.0949540389170667,-0.2508074817058,0.121412350849102,0.495675251727525
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X20255.Spirometry QC measure,43011,-0.0355611753380248,0.062391013156588,-0.157847561124937,0.0867252104488876,0.568703100863667
PON1,Serum paraoxonase/arylesterase 1,Eye measures,X20261.avMSE,29790,-0.000785651933818919,0.00376508256651904,-0.00816521376419625,0.00659390989655841,0.83471544947763
PON1,Serum paraoxonase/arylesterase 1,Eye measures,X20262.Myopia diagnosis,29790,-0.0621429622969297,0.109631357621613,-0.277020423235292,0.152734498641432,0.5708496819352
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X20280.Glucose-lactate,37950,0.0063597249076983,0.00247461422356337,0.0015094810295141,0.0112099687858825,0.0101808799073173
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X20281.Spectrometer-corrected alanine,37980,-0.00130307856217828,0.00237294239491121,-0.00595404565620425,0.00334788853184769,0.582918158077886
PON1,Serum paraoxonase/arylesterase 1,Mental health,X20544#11.Mental health problems ever diagnosed by a professional_Depression,32063,-0.00552484499688177,0.0109274155826313,-0.0269425795388391,0.0158928895450755,0.613155742044837
PON1,Serum paraoxonase/arylesterase 1,Mental health,X20544#6.Mental health problems ever diagnosed by a professional_Panic attacks,32061,-0.0114978243594998,0.0206041674198764,-0.0518819925024574,0.0288863437834579,0.576837638413879
PON1,Serum paraoxonase/arylesterase 1,Mental health,X20546#1.Substances taken for depression_Unprescribed medication (more than once),32060,-0.0369706898334298,0.0258651360693987,-0.0876663565294513,0.0137249768625917,0.152940748595476
PON1,Serum paraoxonase/arylesterase 1,Mental health,X20546#3.Substances taken for depression_Medication prescribed to you (for at least two weeks),32060,0.0015498991321959,0.0102732665170348,-0.0185857032411922,0.021685501505584,0.88008446094261
PON1,Serum paraoxonase/arylesterase 1,Mental health,X20546#4.Substances taken for depression_Drugs or alcohol (more than once),32060,0.0364959501566249,0.0202351095640942,-0.00316486458899979,0.0761567649022495,0.0713343040748903
PON1,Serum paraoxonase/arylesterase 1,Mental health,X20548#1.Manifestations of mania or irritability_I was more talkative than usual,32066,0.00936852896735912,0.0243261427057059,-0.0383107107358245,0.0570477686705427,0.700157901300715
PON1,Serum paraoxonase/arylesterase 1,Mental health,X20548#2.Manifestations of mania or irritability_I was more restless than usual,32066,-0.00449551420334285,0.016587697131277,-0.0370074005806457,0.0280163721739601,0.786386866894102
PON1,Serum paraoxonase/arylesterase 1,Mental health,X20548#3.Manifestations of mania or irritability_My thoughts were racing,32066,2.52395108324659e-05,0.0180488025603666,-0.0353504135074861,0.035400892529151,0.998884272340421
PON1,Serum paraoxonase/arylesterase 1,Mental health,X20548#5.Manifestations of mania or irritability_I needed less sleep than usual,32066,0.0181530633110428,0.0291499719111312,-0.0389808816347743,0.0752870082568599,0.533469312405048
PON1,Serum paraoxonase/arylesterase 1,Mental health,X20548#6.Manifestations of mania or irritability_I was more creative or had more ideas than usual,32066,-0.0123956108283825,0.034823278321856,-0.0806492363392203,0.0558580146824553,0.721882174798144
PON1,Serum paraoxonase/arylesterase 1,Mental health,X20548#7.Manifestations of mania or irritability_I was easily distracted,32066,-0.00290989355144553,0.0189603384214188,-0.0400721568574264,0.0342523697545353,0.87802961700582
PON1,Serum paraoxonase/arylesterase 1,Mental health,X20548#8.Manifestations of mania or irritability_I was more confident than usual,32066,0.00695179537359993,0.0357646213311559,-0.0631468624354657,0.0770504531826656,0.845886418221664
PON1,Serum paraoxonase/arylesterase 1,Mental health,X20548#9.Manifestations of mania or irritability_I was more active than usual,32066,0.0281324173986561,0.0249376956775957,-0.0207454661294315,0.0770103009267436,0.259309798742833
PON1,Serum paraoxonase/arylesterase 1,Mental health,X20549#1.Substances taken for anxiety_Unprescribed medication (more than once),32066,-0.0344706475325906,0.0302464578902216,-0.093753704997425,0.0248124099322437,0.254464251055943
PON1,Serum paraoxonase/arylesterase 1,Mental health,X20549#3.Substances taken for anxiety_Medication prescribed to you (for at least two weeks),32066,0.00885411104778149,0.0139456142212293,-0.018479292825828,0.036187514921391,0.525510816685892
PON1,Serum paraoxonase/arylesterase 1,Mental health,X20549#4.Substances taken for anxiety_Drugs or alcohol (more than once),32066,0.0244739561913831,0.0229088206717844,-0.0204273323253143,0.0693752447080805,0.285409962438721
PON1,Serum paraoxonase/arylesterase 1,Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,32067,0.0371199914451846,0.0334699993755962,-0.0284812073309839,0.102721190221353,0.267442494083081
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20600.Liking for adding salt to foods,33452,-0.0115976598189868,0.0715567757491228,-0.151848940287267,0.128653620649294,0.871249385267068
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20601.Liking for aniseed,33452,0.093743219508887,0.0724363745364222,-0.0482320745825006,0.235718513600275,0.195648353032387
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20602.Liking for apple juice,33452,-0.155382566614115,0.0722997537372485,-0.297090083939122,-0.013675049289108,0.0316496146324009
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20603.Liking for apples,33452,-0.0183586437053928,0.0740767848451526,-0.163549142001892,0.126831854591106,0.804269574063278
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20604.Liking for asparagus,33452,0.305734675492378,0.0740917516460131,0.160514842266192,0.450954508718563,3.71755729582717e-05
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20605.Liking for aubergine,33452,0.250581889554022,0.0715581860449489,0.110327844905922,0.390835934202122,0.000464383369794348
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20606.Liking for avocados,33452,0.302793018172819,0.073880413437924,0.157987407834488,0.44759862851115,4.1963440092836e-05
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20607.Liking for bacon,33452,0.151012937336326,0.0720431739517732,0.00980831639085017,0.292217558281801,0.0360972137037147
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20608.Liking for baked or steamed fish,33452,0.302723979315406,0.0730874528045624,0.159472571818464,0.445975386812348,3.4752846368261e-05
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20609.Liking for bananas,33452,-0.118474072235842,0.0755881986704181,-0.266626941629862,0.0296787971581773,0.117065286150649
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20610.Liking for barbequed or grilled meat,33452,0.322558326611695,0.0716513790486806,0.182121623676281,0.462995029547109,6.82368135211344e-06
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20611.Liking for beef steak,33452,0.214904232977842,0.0718970311573838,0.0739860519093702,0.355822414046315,0.00280597862011234
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20612.Liking for beetroot,33452,0.00545570298984342,0.0742120460150444,-0.139999907199644,0.15091131317933,0.941397895975839
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20613.Liking for bell pepper,33452,0.16672069035377,0.0724611872994943,0.0246967632467612,0.308744617460779,0.0214241571530413
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20614.Liking for bicycling,33452,0.120190909716362,0.0717832276209659,-0.020504216420731,0.260886035853455,0.0940948004724933
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20615.Liking for biscuits,33452,-0.338762983705167,0.0722624660477039,-0.480397417158667,-0.197128550251668,2.80013263890725e-06
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20616.Liking for bitter foods,33452,0.252183593440486,0.0718828950678567,0.111293119107487,0.393074067773485,0.000453259485522978
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20617.Liking for bitter or ale,33452,0.239421272967101,0.0748265438774766,0.0927612469672469,0.386081298966955,0.00138056179052778
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20618.Liking for black olives,33452,0.283130391267741,0.072924118032519,0.140199119924004,0.426061662611479,0.000104113190119281
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20619.Liking for black pepper,33452,0.243955598466993,0.0725535413772487,0.101750657367586,0.386160539566401,0.000775844135007753
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20620.Liking for blue cheese,33452,0.134003031515729,0.0721993687028347,-0.0075077311418266,0.275513794173285,0.0634842729768684
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20621.Liking for bolognese sauce,33452,0.256467494792377,0.072350874773514,0.11465978023629,0.398275209348464,0.000394946393915625
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20622.Liking for broad beans,33452,0.10986458695665,0.072263342040929,-0.0317715634435704,0.251500737356871,0.128461622195431
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20623.Liking for broccoli,33452,0.223769885523863,0.0760686152838748,0.0746753995674682,0.372864371480257,0.00327264882706017
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20624.Liking for brown rice,33452,0.0150237984344817,0.0725638310183166,-0.127201310361419,0.157248907230382,0.83598134034364
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20625.Liking for brussel sprouts,33452,0.0263545125598818,0.0730525204896268,-0.116828427599787,0.16953745271955,0.718286469993895
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20626.Liking for burgers (meat),33452,0.209247475532562,0.0720330047954941,0.0680627861333937,0.350432164931731,0.00368285374698047
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20627.Liking for burn of spicy foods,33452,0.291649512248598,0.0723406214954772,0.149861894117462,0.433437130379733,5.5852274772664e-05
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20628.Liking for butter on bread,33452,-0.142623741063628,0.0740539341148994,-0.287769451928831,0.00252196980157476,0.054142842096976
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20629.Liking for butternut squash,33452,0.0630417768864646,0.0725588819066641,-0.0791736316505971,0.205257185423526,0.384959969092441
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20630.Liking for cabbage,33452,0.0530789365609735,0.0730501992575925,-0.0900994539839078,0.196257327105855,0.467484393067211
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20631.Liking for cake,33452,-0.304947678559519,0.0725850002079823,-0.447214278967164,-0.162681078151874,2.68010136507913e-05
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20632.Liking for cake icing,33452,-0.240208434524784,0.071515138109708,-0.380378105219811,-0.100038763829756,0.000785935559207766
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20633.Liking for capers,33452,0.103233635146844,0.0717623438019023,-0.0374205587048841,0.243887828998573,0.150313202867446
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20634.Liking for cauliflower,33452,0.0253175842932645,0.074212979388838,-0.120139855308858,0.170775023895387,0.733000394759785
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20635.Liking for cereal or granola bar,33452,-0.0165414942642829,0.0717074292098555,-0.1570880555156,0.124005066987034,0.817568395339314
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20636.Liking for cheesecake,33452,-0.153846730586439,0.072077136895141,-0.295117918900915,-0.0125755422719628,0.0328310176408139
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20637.Liking for cherries,33452,0.048081918081335,0.0785737677838849,-0.105922666775079,0.202086502937749,0.540597251957431
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20638.Liking for chicken,33452,0.334255459457831,0.0761862223151948,0.184930463720049,0.483580455195613,1.16049489821616e-05
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20639.Liking for chilli pepper,33452,0.31358738408082,0.0722356851092916,0.172005441266609,0.455169326895032,1.43277789395489e-05
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20640.Liking for chips or french fries,33452,-0.0460922284971865,0.0721606221452042,-0.187527047901787,0.0953425909074138,0.523005176555319
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20641.Liking for cigarette smoking,33452,-0.103020840463842,0.118625020723638,-0.335525881082174,0.129484200154489,0.385166871309238
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20642.Liking for cod,33452,0.212014123725204,0.0744393169047921,0.0661130625918114,0.357915184858597,0.00440743656123019
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20643.Liking for coffee with sugar,33452,-0.164203162502879,0.0819611567513673,-0.324847029735559,-0.00355929527019905,0.0451614719558516
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20644.Liking for coffee without sugar,33452,0.195823196043325,0.0740929058190769,0.0506011006379345,0.341045291448716,0.00823317938168793
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20645.Liking for coriander,33452,0.275541606815939,0.0719206545204785,0.134577123955801,0.416506089676077,0.000128393398051528
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20646.Liking for corn flakes,33452,-0.119291871755751,0.0719876354787518,-0.260387637294105,0.021803893782602,0.0975308889208756
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20647.Liking for cream,33452,-0.0974264891460331,0.072031078696351,-0.238607403390881,0.0437544250988148,0.176229660945538
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20648.Liking for croissant,33452,-0.0606648049899749,0.0717729578650456,-0.201339802405464,0.0800101924255145,0.398003777418743
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20649.Liking for cucumber,33452,0.0377355429106981,0.0731459694273659,-0.105630557166939,0.181101642988335,0.605941358288131
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20650.Liking for curry,33452,0.315288036966909,0.0728825051221074,0.172438326927578,0.458137747006239,1.53497778737004e-05
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20651.Liking for dairy products,33452,-0.0231656900400723,0.0737097512415696,-0.167636802473549,0.121305422393404,0.75331372730016
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20652.Liking for dark chocolate,33452,0.069115285978411,0.0726421483475224,-0.0732633247827328,0.211493896739555,0.341402165591899
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20653.Liking for diet fizzy drinks,33452,0.0410071024048663,0.0754554753739912,-0.106885629328156,0.188899834137889,0.586825961640952
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20654.Liking for dried fruit,33452,0.0156049771015934,0.0720413199454454,-0.12559600999148,0.156805964194666,0.828516051013687
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20655.Liking for eggs,33452,0.14831914615496,0.0753264433252182,0.000679317237532756,0.295958975072388,0.0489816511568161
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20656.Liking for exercising alone,33452,0.150782825828533,0.0715506957604111,0.010543462138127,0.291022189518939,0.0351143040951371
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20657.Liking for exercising with others,33452,0.184103855409743,0.071625340220939,0.0437181885767024,0.324489522242783,0.0101748505940844
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20658.Liking for extra virgin olive oil,33452,0.166964508726045,0.0731215551191386,0.0236462606925337,0.310282756759557,0.0224310459133933
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20659.Liking for fatty foods,33452,-0.0316879115823134,0.0715695396219383,-0.171964209241312,0.108588386076686,0.65795219118759
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20660.Liking for fresh tomatoes,33452,0.0083203410944122,0.0803314413158932,-0.149129283884738,0.165769966073563,0.917508818976011
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20661.Liking for fried chicken,33452,0.0597176401382623,0.0711820946236783,-0.0797992653241472,0.199234545600672,0.401524230193725
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20662.Liking for fried or battered fish,33452,-0.00476578651506666,0.0717407000143654,-0.145377558543223,0.135845985513089,0.947036388445981
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20663.Liking for fruit,33452,-0.0162400446391409,0.083900851940196,-0.180685714441925,0.148205625163643,0.846522966717023
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20664.Liking for garlic,33452,0.355289749777712,0.0737074186222792,0.210823209278045,0.499756290277379,1.45712632016034e-06
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20665.Liking for gherkins,33452,0.0501331286758535,0.0713226126830185,-0.0896591921828627,0.18992544953457,0.482132213604452
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20666.Liking for globe artichoke,33452,0.200781554770905,0.0724408977624746,0.0587973951564544,0.342765714385355,0.00558859011306472
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20667.Liking for goat's cheese,33452,0.294552390159006,0.0718025913825168,0.153819311049273,0.435285469268739,4.12755207375969e-05
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20668.Liking for going to a cafe,33452,-0.202494060724697,0.0733127135619735,-0.346186979306165,-0.0588011421432295,0.00575546923086265
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20669.Liking for going to the gym,33452,0.161154846637374,0.0715835196043005,0.0208511482129451,0.301458545061803,0.0243915901447856
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20670.Liking for going to the pub,33452,0.470226843607281,0.0715926580836073,0.329905233763411,0.610548453451151,5.37908242009365e-11
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20671.Liking for grapefruit,33452,0.0930648506134601,0.0718254201657536,-0.047712972911417,0.233842674138337,0.195108987240583
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20672.Liking for green olives,33452,0.278663443222556,0.0729494725440773,0.135682477036164,0.421644409408947,0.000134376231405687
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20673.Liking for haddock,33452,0.318503816491013,0.073760615128402,0.173933010839345,0.463074622142681,1.59084895630843e-05
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20674.Liking for ham,33452,0.18461919088286,0.0718030458481496,0.0438852210204872,0.325353160745234,0.0101509346019174
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20675.Liking for hard cheese,33452,0.106436085108245,0.0744753511342402,-0.0395356031148657,0.252407773331356,0.152997267033143
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20676.Liking for herring,33452,0.291168021089895,0.0715687914522393,0.150893189843505,0.431442852336284,4.77486022561648e-05
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20677.Liking for honey,33452,0.0398738678270238,0.0722239568475704,-0.101685087594214,0.181432823248262,0.580902848435599
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20678.Liking for horseradish or wasabi,33452,0.265523719995077,0.0721793515318518,0.124052190992648,0.406995248997507,0.000235826089480583
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20679.Liking for ice cream,33452,-0.0443163912520922,0.0725536870261247,-0.186521617823297,0.0978888353191123,0.541341965302037
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20680.Liking for jam,33452,-0.243080133021579,0.0719339169720308,-0.384070610286759,-0.102089655756398,0.000730022473185701
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20681.Liking for kiwi fruit,33452,0.063658239601146,0.0722956213968822,-0.078041178336743,0.205357657539035,0.378597473133488
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20682.Liking for lager,33452,0.248001173722655,0.0726829216119221,0.105542647363288,0.390459700082023,0.000647492389141356
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20683.Liking for lamb,33452,0.21861950375221,0.0722665850698197,0.076976997015363,0.360262010489056,0.00249186469717088
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20684.Liking for lemons,33452,0.0829748730005894,0.0729355510074079,-0.0599788069739301,0.225928552975109,0.255298444614362
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20685.Liking for lentils or beans,33452,0.0142208418622127,0.0725745090110889,-0.128025195799522,0.156466879523947,0.84465516601803
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20686.Liking for liver,33452,0.300302851235913,0.0724194616471188,0.15836070640756,0.442244996064266,3.40379234496927e-05
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20687.Liking for mackerel,33452,0.306319423256466,0.0717591915127672,0.165671407891443,0.44696743862149,1.98621917312069e-05
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20688.Liking for marzipan,33452,-0.12164635989965,0.0715977492722249,-0.261977948473211,0.0186852286739106,0.089349084219337
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20689.Liking for mayonnaise,33452,0.222347971971853,0.0720466324094399,0.081136572449351,0.363559371494355,0.00203370986383822
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20690.Liking for melon,33452,0.0265931156244563,0.0758046724228402,-0.121984042324311,0.175170273573223,0.725738336686625
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20691.Liking for milk chocolate,33452,-0.145303064270617,0.0721795827421345,-0.286775046445201,-0.00383108209603347,0.0441362694515507
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20692.Liking for mushrooms,33452,0.0824517297651792,0.0743996504287455,-0.063371585075162,0.22827504460552,0.267793272794917
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20694.Liking for orange juice,33452,-0.0299061418654431,0.0721306915618169,-0.171282297326604,0.111470013595718,0.678436954346918
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20695.Liking for oranges,33452,-0.0309804106512407,0.0743989959566664,-0.176802442726307,0.114841621423825,0.677120692044044
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20696.Liking for pasta,33452,0.180609257668273,0.0726217321436041,0.038270662666809,0.322947852669737,0.0129010312602977
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20697.Liking for pears,33452,-0.142714239416825,0.0746901814475469,-0.289106995054017,0.00367851622036652,0.0560685299760681
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20698.Liking for pizza,33452,0.0460633960688291,0.0714289202030894,-0.0939372875292262,0.186064079666884,0.519018558106281
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20699.Liking for plain yogurt,33452,0.244821889217437,0.0725886187490987,0.102548196469204,0.38709558196567,0.000747406984826494
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20700.Liking for plums,33452,0.065113510789609,0.0745817715276824,-0.0810667614046485,0.211293782983867,0.38265990694554
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20701.Liking for pollock,33452,0.353305953385916,0.0718083039537969,0.212561677636474,0.494050229135358,8.8022885967872e-07
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20702.Liking for pork chop,33452,0.238327408677414,0.071312702363203,0.0985545120455359,0.378100305309292,0.000835148356011388
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20703.Liking for porridge,33452,-0.0591742970186675,0.07414455308797,-0.204497621071089,0.0861490270337537,0.424837224492572
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20704.Liking for potato crisps,33452,-0.096658083652138,0.0724466495809646,-0.238653516830829,0.0453373495265526,0.182173178562087
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20705.Liking for potatoes,33452,-0.102886774187267,0.0731882526079399,-0.246335749298829,0.0405622009242957,0.159823233002459
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20706.Liking for prawns,33452,0.370044219385251,0.0730345678733203,0.226896466353544,0.513191972416959,4.12822859856686e-07
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20707.Liking for raw carrots,33452,0.165023166703619,0.0732460603582642,0.0214608884014215,0.308585445005817,0.0242833307847477
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20708.Liking for red meat,33452,0.200529540564847,0.0720619655224138,0.0592880881409159,0.341770992988778,0.0054014827841551
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20709.Liking for red wine,33452,0.434219035691354,0.0717989409424501,0.293493111444152,0.574944959938557,1.5277960471298e-09
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20710.Liking for regular (non-diet) fizzy drinks,33452,-0.119279538999977,0.075686587835895,-0.267625251158332,0.0290661731583769,0.115068669552174
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20711.Liking for roast chicken,33452,0.276738609027967,0.0766217852978866,0.126559909844109,0.426917308211825,0.000305797077960428
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20712.Liking for salad dressing,33452,0.110723256184402,0.072129851940018,-0.0306512536180334,0.252097765986837,0.124805619807994
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20713.Liking for salad leaves,33452,0.183003024129142,0.0749888547434806,0.0360248688319204,0.329981179426364,0.0146900612745764
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20714.Liking for salami,33452,0.346006758010242,0.0723396600542365,0.204221024303939,0.487792491716546,1.75370340450344e-06
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20715.Liking for salmon,33452,0.278233971584279,0.076888747099949,0.127532027268379,0.428935915900179,0.000297761772268756
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20716.Liking for salty foods,33452,-0.0873881966818323,0.0714004443512456,-0.227333067610274,0.0525566742466091,0.22101572206189
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20717.Liking for salty pretzels,33452,0.00253952403734809,0.0722011527959376,-0.13897473544269,0.144053783517386,0.971942651111031
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20718.Liking for sardines,33452,0.272513367745186,0.0718430952567244,0.131700901042007,0.413325834448366,0.00014970852005673
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20719.Liking for sausages (meat),33452,0.188266053967402,0.0717731364190753,0.0475907065860139,0.328941401348789,0.00872881000776493
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20720.Liking for savoury biscuits,33452,-0.0662639462495151,0.0723328570554449,-0.208036346078187,0.0755084535791569,0.3596403524368
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20721.Liking for shellfish (other than prawns),33452,0.399724631754595,0.0716616813258912,0.259267736355848,0.540181527153341,2.50433430129988e-08
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20722.Liking for skimmed milk,33452,0.236320211634269,0.0724526871368743,0.0943129448459958,0.378327478422543,0.00111152146115787
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20723.Liking for smoked fish,33452,0.370596632984362,0.0718311691937242,0.229807541364663,0.511385724604062,2.53201470182079e-07
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20724.Liking for soft cheese,33452,0.195877716462545,0.0720682445675495,0.0546239571101478,0.337131475814942,0.00658141221946976
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20725.Liking for soy sauce,33452,0.0768725700100107,0.0720559466135753,-0.0643570853525968,0.218102225372618,0.286070206023186
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20726.Liking for soya milk,33452,-0.075950685133257,0.0723530599448216,-0.217762682625107,0.0658613123585933,0.293873611520555
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20727.Liking for spicy foods,33452,0.388129848952872,0.0723677103171123,0.246289136731332,0.529970561174412,8.3743979305496e-08
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20728.Liking for spinach,33452,0.220521128779354,0.0732147874354839,0.0770201454058059,0.364022112152903,0.00260275522879202
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20729.Liking for spirits,33452,0.329671021242387,0.0717688313576574,0.189004111781379,0.470337930703396,4.41776291043449e-06
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20730.Liking for strawberries,33452,0.0250852012139615,0.0821979148709586,-0.136022711933117,0.18619311436104,0.760235743325121
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20731.Liking for sweet coffee house drinks,33452,-0.0249435736439426,0.0748670832451832,-0.171683056804502,0.121795909516617,0.739012646867081
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20732.Liking for sweet foods,33452,-0.44502175164963,0.0720954998325389,-0.586328931321406,-0.303714571977854,7.00504657133486e-10
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20733.Liking for taking the stairs,33452,0.196164456721996,0.073556097537358,0.0519945055487748,0.340334407895218,0.0076698653592022
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20734.Liking for tea with sugar,33452,-0.133556756224834,0.0958080402197136,-0.321340515055473,0.0542270026058043,0.163350956585959
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20735.Liking for tea without sugar,33452,0.0807860785666866,0.0768871500801625,-0.0699127355904319,0.231484892723805,0.293420154227012
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20736.Liking for tomato ketchup,33452,-0.0491458473956513,0.0713978072771511,-0.189085549658867,0.0907938548675649,0.491257508784574
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20737.Liking for tinned tuna,33452,0.226740583947451,0.0722874458679899,0.0850571900461914,0.368423977848712,0.00171440072327353
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20738.Liking for turnip (white),33452,-0.0112941532769727,0.0720625457764571,-0.152536742998829,0.129948436444883,0.875463453186526
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20739.Liking for vegetables,33452,0.109751637110058,0.0840223906068459,-0.05493224847936,0.274435522699476,0.191511532033121
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20740.Liking for vinegar,33452,0.0150923019250604,0.0716315207452659,-0.125305478735661,0.155490082585782,0.833131155098595
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20741.Liking for watching television,33452,-0.0492603162268391,0.0730721185580925,-0.1924816686007,0.0939610361470222,0.500244181425634
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20742.Liking for whisky,33452,0.210293660703493,0.0776452719872703,0.0581089276084436,0.362478393798543,0.00677385155482454
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20743.Liking for white bread,33452,-0.0659152924567898,0.0715653532745517,-0.206183384874911,0.0743527999613315,0.35704886142751
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20744.Liking for white rice,33452,0.0479850349967007,0.0721719414784844,-0.0934719703011288,0.18944204029453,0.506150022055539
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20745.Liking for white wine,33452,0.601963392458285,0.0722734244845373,0.460307480468592,0.743619304447978,9.35151080812686e-17
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20746.Liking for whole grain breakfast cereal,33452,0.0235781918553958,0.0727692281987965,-0.119049495414245,0.166205879125037,0.745935563329449
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20747.Liking for whole milk,33452,-0.0712721771377868,0.0721760429413773,-0.212737221302886,0.0701928670273127,0.323435460958719
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20748.Liking for wholemeal bread,33452,0.0696710107626027,0.0761113341527469,-0.0795072041767812,0.218849225701987,0.360015222307676
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X20749.Liking for working up a sweat,33452,0.239643331635541,0.0718501464456811,0.0988170446020058,0.380469618669075,0.000855458259480702
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X21001.Body mass index (BMI),48581,0.0252589962982948,0.00680728785804232,0.0119167120965319,0.0386012805000577,0.000207247882968484
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X21002.Weight,48588,-0.00412735728805461,0.00423492054790035,-0.0124278015619393,0.00417308698583007,0.329768044940167
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X21021.Pulse wave Arterial Stiffness index,32524,-0.0021289956534899,0.00309374170871074,-0.00819272940256295,0.00393473809558315,0.491370510724605
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X21025.Frequency of discomfort or pain in abdomen in last 3 months,32968,-0.13480592369588,0.0757421264774283,-0.28326049159164,0.013648644199879,0.0751441805152578
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X21033.Frequency of hard or lumpy stools in the last 3 months,32982,0.0336684480012403,0.078968565805892,-0.121109940978308,0.188446836980789,0.669861746715321
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X21034.Frequency of loose or mushy or watery stools in the last 3 months,32983,0.00137672879030043,0.0793224158987388,-0.154095206371228,0.156848663951829,0.986152926881885
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X21040.Satisfaction with bowel habits,32936,-0.0277878507368808,0.0739478577479345,-0.172725651922832,0.117149950449071,0.707092630137227
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X21041.Degree to which abdominal pain or discomfort or altered bowel habits affect or interfere with life in general,32921,-0.199722188489708,0.0767027113926176,-0.350059502819239,-0.049384874160178,0.00923447407324264
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X21042.Greatest number of times bowels opened per day,32933,-0.0999533169167057,0.0789638375811506,-0.254722438575761,0.0548158047423496,0.205615427633027
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X21043.Least number of times bowels opened per week,32851,0.0831247133597008,0.0779978514653833,-0.0697510755124504,0.236000502231852,0.286575984424545
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X21044.Average number of times bowels opened per day,32900,0.00899613752155647,0.0891200301279935,-0.165679121529311,0.183671396572424,0.919597265939444
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X21048.Degree bothered by back pain in the past 3 months,32985,0.148237812076803,0.0792057370910387,-0.00700543262163253,0.303481056775239,0.0613025269598587
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X21049.Degree bothered by pain in arms or legs or joints in the past 3 months,32979,0.205860760917875,0.0802146381902543,0.0486400700649768,0.363081451770774,0.0102937172080884
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X21050.Degree bothered by menstrual cramps or other problems with period in the last 3 months,32983,-0.0978197238842404,0.0939213678923447,-0.281905604953236,0.0862661571847553,0.297670016155011
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X21051.Degree bothered by headaches in the last 3 months,32982,0.234467805418394,0.0832432792157799,0.0713109781554656,0.397624632681323,0.00486377346332706
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X21052.Degree bothered by chest pain in the last 3 months,32979,0.250932711797413,0.121517105072027,0.0127591858562404,0.489106237738585,0.0389532478998928
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X21053.Degree bothered by dizziness in the last 3 months,32980,0.0424096417191292,0.0909286887681683,-0.135810588266481,0.220629871704739,0.640937180918398
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X21054.Degree bothered by fainting spells in the last 3 months,32980,-0.00274169323692365,0.229047430885197,-0.45167465777191,0.446191271298063,0.990449845614361
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X21055.Degree bothered by feeling heart pound or race in the last 3 months,32984,0.102702241356787,0.0863988640119067,-0.0666395321065498,0.272044014820125,0.234591230596415
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X21056.Degree bothered by shortness of breath in the last 3 months,32983,0.232170351787345,0.0904072325403882,0.0549721760081844,0.409368527566506,0.0102440922731166
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X21057.Degree bothered by pain or problems during intercourse in the last 3 months,32746,-0.235784543861547,0.0820941849492867,-0.396689146362149,-0.0748799413609447,0.00408759093931213
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X21058.Degree bothered by urinary frequency or bladder irritability in the last 3 months,32981,0.0826291076484955,0.0819354461185845,-0.0779643667439301,0.243222582040921,0.313259437343541
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X21059.Degree bothered by nausea in the last 3 months,32982,0.211989210299379,0.10655737760443,0.00313675019469606,0.420841670404063,0.0466848530347753
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X21060.Degree bothered by feeling tired all the time in the last 3 months,32985,0.305445868305658,0.0798961560053413,0.148849402535189,0.462042334076127,0.000132756421792714
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X21061.Degree bothered by trouble sleeping in the last 3 months,32984,-0.0254655372766623,0.0795004678607444,-0.181286454283721,0.130355379730397,0.748734109888991
PON1,Serum paraoxonase/arylesterase 1,Working and living environment,X21100.Water hardness (USGS classification),48462,0.0219023628305876,0.0457617250905673,-0.0677906183469243,0.1115953440081,0.632215119205265
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X2139.Age first had sexual intercourse,45237,-0.000822854157851693,0.00218094976486977,-0.00509751569699645,0.00345180738129306,0.705960721194705
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X2149.Lifetime number of sexual partners,43904,0.0417829343663057,0.050703797153205,-0.057596508053976,0.141162376786587,0.409915982361899
PON1,Serum paraoxonase/arylesterase 1,Physical activities,X22032.IPAQ activity group,43105,0.164337941395161,0.0508833553821839,0.064606564846081,0.264069317944242,0.00124135010355085
PON1,Serum paraoxonase/arylesterase 1,Physical activities,X22033.Summed days activity,43713,0.00772683168149862,0.00203943841070965,0.0037295323965077,0.0117241309664895,0.000151894909415107
PON1,Serum paraoxonase/arylesterase 1,Physical activities,X22034.Summed minutes activity,43105,0.00734301188537056,0.00205038611793449,0.00332425509421897,0.0113617686765222,0.000342781036347895
PON1,Serum paraoxonase/arylesterase 1,Physical activities,X22037.MET minutes per week for walking,42192,0.00789519565836909,0.00207375522467338,0.00383063541800926,0.0119597558987289,0.000141023358466491
PON1,Serum paraoxonase/arylesterase 1,Physical activities,X22038.MET minutes per week for moderate activity,43105,0.00298354899744303,0.00202665317666969,-0.000988691228829552,0.00695578922371562,0.140995712273459
PON1,Serum paraoxonase/arylesterase 1,Physical activities,X22039.MET minutes per week for vigorous activity,43105,0.266340223723543,0.0516488030247256,0.165108569795081,0.367571877652005,2.53834917681538e-07
PON1,Serum paraoxonase/arylesterase 1,Physical activities,X22040.Summed MET minutes per week for all activity,42192,0.00753791800915137,0.00211211104672184,0.00339818035757657,0.0116776556607262,0.000359426079276928
PON1,Serum paraoxonase/arylesterase 1,Eye measures,X2217.Age started wearing glasses or contact lenses,45281,0.00475026267691584,0.00194170743089935,0.000944516112353109,0.00855600924147857,0.0144358564331875
PON1,Serum paraoxonase/arylesterase 1,Working and living environment,X22501.Year ended full time education,30302,0.0264556853043025,0.00895862176548893,0.00889678664394419,0.0440145839646608,0.003158539555957
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X22506.Tobacco smoking,30270,-0.112061966235245,0.195656948174619,-0.495549584657498,0.271425652187008,0.566838024608226
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X2277.Frequency of solarium or sunlamp use,47034,0.176513255115236,0.109794239634926,-0.0386834545692179,0.391709964799691,0.107920754839136
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X23098.Weight,48220,-0.00464566471639496,0.00427166765956695,-0.0130181333291462,0.00372680389635627,0.276803544325146
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X23099.Body fat percentage,48221,0.0391699488636261,0.00437100139731342,0.0306027861248918,0.0477371116023604,3.4384923902768e-19
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X23100.Whole body fat mass,48215,0.0223029486826753,0.00419545325841835,0.0140798602961754,0.0305260370691753,1.0704143545219e-07
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X23101.Whole body fat-free mass,48220,-0.0202653456837097,0.00350511847147121,-0.0271353778877932,-0.0133953134796261,7.49000226634425e-09
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X23102.Whole body water mass,48220,-0.0207321174540019,0.0035178899886174,-0.027627181831692,-0.0138370530763118,3.83573925729084e-09
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X23104.Body mass index (BMI),48220,0.0245805360959843,0.00690037103463316,0.0110558088681033,0.0381052633238653,0.000368472201803044
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X23105.Basal metabolic rate,48218,-0.0189830608883269,0.00382250226643895,-0.0264751653305473,-0.0114909564461066,6.87737575732001e-07
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X23106.Impedance of whole body,48214,0.0258931563706772,0.00285952581030239,0.0202884857824846,0.0314978269588699,1.46734263122939e-19
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X23107.Impedance of leg (right),48217,0.0235163974510259,0.00235049943538603,0.0189094185576693,0.0281233763443826,1.61529226205429e-23
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X23108.Impedance of leg (left),48216,0.0229402556063699,0.00232349451788636,0.0183862063513126,0.0274943048614271,6.02445219975524e-23
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X23109.Impedance of arm (right),48209,0.0141232732826358,0.00287137526410176,0.00849537776499634,0.0197511688002752,8.77276976223779e-07
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X23110.Impedance of arm (left),48215,0.0158060320531793,0.00287731648348856,0.0101664917455417,0.0214455723608168,3.98481145695789e-08
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X23111.Leg fat percentage (right),48216,0.0684372493449954,0.00689440059791746,0.0549242241730772,0.0819502745169137,3.54238330819403e-23
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X23112.Leg fat mass (right),48215,0.0427073028109272,0.00792562538044809,0.0271730770652489,0.0582415285566054,7.17202740451098e-08
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X23113.Leg fat-free mass (right),48215,-0.0238837258123119,0.00356810756909275,-0.0308772166477337,-0.0168902349768901,2.22492742378329e-11
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X23114.Leg predicted mass (right),48214,-0.0239585457949836,0.00358209292428432,-0.0309794479265808,-0.0169376436633863,2.30600025789293e-11
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X23115.Leg fat percentage (left),48211,0.0673901036675092,0.00711709022879311,0.0534406068190747,0.0813396005159437,3.0865772928438e-21
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X23116.Leg fat mass (left),48211,0.0437410921268323,0.00795962918511293,0.0281402189240109,0.0593419653296536,3.93899485670995e-08
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X23117.Leg fat-free mass (left),48209,-0.0227399283603637,0.00365737490760407,-0.0299083831792677,-0.0155714735414597,5.13370253221688e-10
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X23118.Leg predicted mass (left),48208,-0.0220917424650646,0.00367267379914497,-0.0292901831113887,-0.0148933018187404,1.82329973567475e-09
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X23119.Arm fat percentage (right),48208,0.0300283845984273,0.00485054801602596,0.0205213104870164,0.0395354587098382,6.08704418539955e-10
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X23120.Arm fat mass (right),48207,0.0184243105727454,0.00437371877001264,0.0098518217835206,0.0269967993619701,2.53485263985239e-05
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X23121.Arm fat-free mass (right),48208,-0.0137598916800326,0.00341832917997592,-0.0204598168727854,-0.00705996648727982,5.70726747794366e-05
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X23122.Arm predicted mass (right),48207,-0.0126642238091867,0.00341588841367364,-0.0193593650999871,-0.00596908251838641,0.000209835397947136
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X23123.Arm fat percentage (left),48204,0.0353107383510896,0.00545234738842387,0.0246241374697788,0.0459973392324003,9.5872108208687e-11
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X23124.Arm fat mass (left),48204,0.0184613927449679,0.00449146937197111,0.00965811277590454,0.0272646727140313,3.96431298143628e-05
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X23125.Arm fat-free mass (left),48204,-0.0118788974150595,0.0036826441532494,-0.0190968799554283,-0.0046609148746907,0.00125859873428515
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X23126.Arm predicted mass (left),48202,-0.012173470413541,0.00368924579246732,-0.0194043921667769,-0.00494254866030503,0.000969245100479843
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X23127.Trunk fat percentage,48201,0.0199243187760933,0.0027616171079695,0.0145115492444731,0.0253370883077135,5.56631538326129e-13
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X23128.Trunk fat mass,48197,0.0148223116959277,0.00318858735777721,0.00857268047468432,0.021071942917171,3.36071285728748e-06
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X23129.Trunk fat-free mass,48192,-0.0173440251837374,0.00327105495604892,-0.0237552928975933,-0.0109327574698816,1.15392364203504e-07
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X23130.Trunk predicted mass,48189,-0.0167531101921968,0.00327859557986269,-0.0231791575287277,-0.0103270628556659,3.24923540641409e-07
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23400.Total Cholesterol,37987,0.050052221100162,0.00242042975502796,0.0453081787803072,0.0547962634200168,1.4843136543249e-93
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23401.Total Cholesterol Minus HDL-C,37987,0.0277024538910237,0.00236390923351615,0.023069191793332,0.0323357159887154,1.44852530796907e-31
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,"X23402.Remnant Cholesterol (Non-HDL, Non-LDL -Cholesterol)",37987,0.0229057751670552,0.00236462000045618,0.0182711199661611,0.0275404303679493,4.04502206316935e-22
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23403.VLDL Cholesterol,37987,0.00345320334905748,0.00232575702701114,-0.00110528042388436,0.00801168712199931,0.137629292609166
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23404.Clinical LDL Cholesterol,37987,0.0303142823274205,0.00236381802837822,0.0256811989917992,0.0349473656630418,1.97971078679249e-37
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23405.LDL Cholesterol,37987,0.0310871685087945,0.00236117848434809,0.0264592586794722,0.0357150783381167,2.40409913520948e-39
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23406.HDL Cholesterol,37987,0.0833359915515421,0.00265733206418206,0.0781276207057453,0.088544362397339,1.81570576854138e-208
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23407.Total Triglycerides,37987,-0.00908014586654827,0.00251576419693628,-0.0140110436925434,-0.00414924804055317,0.000308133243029638
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23408.Triglycerides in VLDL,37987,-0.0126563311012011,0.00251618905672887,-0.0175880616523897,-0.00772460055001256,4.96865590705888e-07
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23409.Triglycerides in LDL,37987,0.00462565401590299,0.00250740392458014,-0.000288857676274077,0.00954016570808006,0.065088747079639
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23410.Triglycerides in HDL,37987,0.00329451173847756,0.00237066513716739,-0.00135199193037052,0.00794101540732563,0.164643057299996
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23411.Total Phospholipids in Lipoprotein Particles,37987,0.060916495643823,0.00244948116343335,0.0561155125634937,0.0657174787241524,1.5606276539658e-133
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23412.Phospholipids in VLDL,37987,-0.00432909450519902,0.00239594918726256,-0.00902515491223363,0.00036696590183559,0.070809579339349
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23413.Phospholipids in LDL,37987,0.0272055371302338,0.00234720739383653,0.0226050106383142,0.0318060636221534,6.43625700380998e-31
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23414.Phospholipids in HDL,37987,0.0779697862911526,0.00257617416812877,0.0729204849216202,0.083019087660685,9.25877068401824e-195
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23415.Total Esterified Cholesterol,37987,0.0533455117694488,0.00242404560370894,0.0485943823861793,0.0580966411527183,1.73588650879561e-105
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23416.Cholesteryl Esters in VLDL,37987,0.00630291025873083,0.00231086795814022,0.00177360906077601,0.0108322114566857,0.00638970209930393
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23417.Cholesteryl Esters in LDL,37987,0.0295577152535927,0.00235722738936449,0.0249375495704383,0.0341778809367471,7.20965371267844e-36
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23418.Cholesteryl Esters in HDL,37987,0.0828308431192309,0.00263978883352478,0.0776568570055223,0.0880048292329395,1.1021173989312e-208
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23419.Total Free Cholesterol,37987,0.0409903876598149,0.00241012693280113,0.0362665388715247,0.0457142364481051,3.3476931681964e-64
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23420.Free Cholesterol in VLDL,37987,-0.000516624766073093,0.00236774593057382,-0.00515740678999777,0.00412415725785159,0.827282298706047
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23421.Free Cholesterol in LDL,37987,0.0343072792640622,0.00237930060372652,0.0296438500807583,0.0389707084473662,8.720609975198e-47
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23422.Free Cholesterol in HDL,37987,0.0797146337101108,0.00267492141551547,0.0744717877357005,0.0849574796845211,4.55905716023725e-189
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23423.Total Lipids in Lipoprotein Particles,37987,0.0423730766753605,0.00241929856104373,0.0376312514957148,0.0471149018550062,6.21149371833095e-68
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23424.Total Lipids in VLDL,37987,-0.0063386801385297,0.00244415306881498,-0.0111292201534071,-0.00154814012365235,0.00951329310796529
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23425.Total Lipids in LDL,37987,0.0292686396851293,0.00235776846107927,0.0246474135014139,0.0338898658688446,3.42272276864086e-35
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23426.Total Lipids in HDL,37987,0.0805666594760666,0.00260584600557514,0.0754592013051393,0.0856741176469939,7.18923703753703e-203
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23427.Total Concentration of Lipoprotein Particles,37987,0.0789079490433873,0.00242886020501624,0.0741473830415555,0.0836685150452191,5.19553717782249e-223
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23428.Concentration of VLDL Particles,37987,0.00069750595300071,0.00235982103457121,-0.00392774327475887,0.00532275518076029,0.767558603192426
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23429.Concentration of LDL Particles,37987,0.0158505372093424,0.00234791260716891,0.0112486284992913,0.0204524459193935,1.52912317898374e-11
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23430.Concentration of HDL Particles,37987,0.0794530592097964,0.00243265170617916,0.0746850618656853,0.0842210565539076,2.74254588163921e-225
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23431.Average Diameter for VLDL Particles,37987,-0.0225986717431403,0.0026498693863144,-0.0277924157403165,-0.017404927745964,1.64248570758944e-17
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23432.Average Diameter for LDL Particles,37987,0.020745735651491,0.00241434017736972,0.0160136289038464,0.0254778423991357,9.41566344584301e-18
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23433.Average Diameter for HDL Particles,37987,0.0464469646513016,0.00285218264648486,0.0408566866641913,0.0520372426384119,4.61278413388457e-59
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23434.Phosphoglycerides,37974,0.0648913512417268,0.0024541794736949,0.0600811594732848,0.0697015430101688,2.9458292300466e-150
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23435.Triglycerides to Phosphoglycerides ratio,37974,-0.0433302384250016,0.00264586096747414,-0.0485161259212509,-0.0381443509287523,1.05419089285814e-59
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23436.Total Cholines,37974,0.0664675137687235,0.0024587252280298,0.061648412321785,0.0712866152156619,8.497692701401e-157
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23437.Phosphatidylcholines,37974,0.065140187578856,0.0024619250624939,0.060314814456368,0.0699655607013441,1.87748951672377e-150
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23438.Sphingomyelins,37973,0.0619293413002151,0.00248096063938333,0.0570666584470238,0.0667920241534065,1.72087090687757e-134
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23439.Apolipoprotein B,37987,0.0159647166112064,0.00234715576589546,0.0113642913100513,0.0205651419123615,1.07711845757303e-11
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23440.Apolipoprotein A1,37987,0.0794563344444677,0.00252095850992451,0.0745152557650156,0.0843974131239197,1.78858999791407e-210
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23441.Apolipoprotein B to Apolipoprotein A1 ratio,37987,-0.0244563530409921,0.0023642114238291,-0.0290902074316971,-0.0198224986502871,5.49719469328177e-25
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23442.Total Fatty Acids,37974,0.0341838870514261,0.00250342887420633,0.0292771664579817,0.0390906076448705,3.59659076861522e-42
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23443.Degree of Unsaturation,37974,0.0463098297639795,0.00259910013814826,0.0412155934932089,0.0514040660347501,3.2674358896832e-70
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23444.Omega-3 Fatty Acids,37974,0.0410066927522952,0.00243255779366535,0.0362388794767111,0.0457745060278793,4.07546005818484e-63
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23445.Omega-6 Fatty Acids,37974,0.0428651767457456,0.00241279991492141,0.0381360889124996,0.0475942645789916,8.07759004664296e-70
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23446.Polyunsaturated Fatty Acids,37974,0.047702192184922,0.0024276953458953,0.0429439093069673,0.0524604750628768,8.90949527849336e-85
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23447.Monounsaturated Fatty Acids,37974,0.0136123653091327,0.00258248791907445,0.00855068898774675,0.0186740416305186,1.3774867864455e-07
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23448.Saturated Fatty Acids,37974,0.0350795862132341,0.00255308941238721,0.0300755309649552,0.0400836414615131,1.13031157013879e-42
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23449.Linoleic Acid,37974,0.0301313574829059,0.00240240321455491,0.0254226471823783,0.0348400677834335,6.94906815699543e-36
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23450.Docosahexaenoic Acid,37974,0.0555569869638299,0.00253762063934009,0.0505832505107233,0.0605307234169364,1.94044991504082e-104
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23451.Omega-3 Fatty Acids to Total Fatty Acids percentage,37974,0.0310139719387951,0.00243390445056726,0.0262435192156833,0.0357844246619069,5.60132288379663e-37
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23452.Omega-6 Fatty Acids to Total Fatty Acids percentage,37974,-0.000329902117728893,0.00275735022484558,-0.00573430855842624,0.00507450432296845,0.904766449969347
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23453.Polyunsaturated Fatty Acids to Total Fatty Acids percentage,37974,0.0169313820504596,0.00275816997502819,0.0115253688994044,0.0223373952015149,8.55644286344119e-10
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23454.Monounsaturated Fatty Acids to Total Fatty Acids percentage,37974,-0.0352424233827372,0.0027108983914836,-0.040555784230045,-0.0299290625354293,2.07092547255033e-38
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23455.Saturated Fatty Acids to Total Fatty Acids percentage,37974,0.0144173942710974,0.00256023674999899,0.00939933024109943,0.0194354583010955,1.82445912641409e-08
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23456.Linoleic Acid to Total Fatty Acids percentage,37974,-0.00254108098837182,0.00264992944176098,-0.00773494269422333,0.00265278071747969,0.337614169031073
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23457.Docosahexaenoic Acid to Total Fatty Acids percentage,37974,0.0361041123358157,0.00259292754349358,0.0310219743505682,0.0411862503210631,9.06872384099622e-44
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23458.Polyunsaturated Fatty Acids to Monounsaturated Fatty Acids ratio,37974,0.0286157666815923,0.00274304012405722,0.0232394080384401,0.0339921253247444,2.20786918629441e-25
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23459.Omega-6 Fatty Acids to Omega-3 Fatty Acids ratio,37972,-0.0276749466531327,0.00242879626321028,-0.0324353873290249,-0.0229145059772406,6.09892431227268e-30
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23460.Alanine,37980,-0.002009738731213,0.00236263904407233,-0.00664051125759476,0.00262103379516876,0.394988308958287
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23461.Glutamine,37942,-0.0127110023875341,0.00237627539292083,-0.017368502157659,-0.00805350261740932,8.9821835610772e-08
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23462.Glycine,37970,-0.0156436810104449,0.00225805826636669,-0.0200694752125236,-0.0112178868083662,4.46351987994285e-12
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23463.Histidine,37968,0.00197825337937366,0.00231327495389983,-0.00255576553027,0.00651227228901733,0.392469798440216
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23464.Total Concentration of Branched-Chain Amino Acids (Leucine + Isoleucine + Valine),37977,-0.00424429115781101,0.00236872398393253,-0.00888699016631878,0.000398407850696752,0.0731865758693275
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23465.Isoleucine,37983,-0.00873082317562087,0.00232005006704618,-0.0132781213070314,-0.00418352504421036,0.000168458259686039
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23466.Leucine,37984,-0.00484502192228491,0.00236584238952554,-0.00948207300575496,-0.000207970838814863,0.0405885077075227
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23467.Valine,37977,-0.00183247974233371,0.00239126456885158,-0.00651935829728281,0.00285439881261538,0.443497832990596
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23468.Phenylalanine,37983,-0.0123161457535815,0.00231129503362234,-0.0168462840194813,-0.00778600748768171,1.00517035103625e-07
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23469.Tyrosine,37968,-0.00384861832855296,0.00233622621641178,-0.00842762171272005,0.000730385055614121,0.0995062001853413
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23470.Glucose,37960,0.00261100693403817,0.00246423557342663,-0.00221889478987802,0.00744090865795436,0.289363489527315
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23471.Lactate,37958,0.00331641036594158,0.00232133320060459,-0.00123340270724342,0.00786622343912658,0.153123312079727
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23472.Pyruvate,37944,-0.000546133688254816,0.00237166348194138,-0.00519459411285992,0.00410232673635028,0.817881943870181
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23473.Citrate,37986,-0.00565799657748724,0.00236139153897248,-0.0102863239938733,-0.00102966916110117,0.0165866208429679
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23474.3-Hydroxybutyrate,37819,0.0065933862964206,0.00223387336616396,0.00221499449873925,0.010971778094102,0.0031673369038441
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23475.Acetate,37977,0.00179495127666347,0.00239893287605195,-0.00290695716039836,0.0064968597137253,0.454335019243386
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23476.Acetoacetate,37986,0.0117359121295622,0.00230199834564311,0.00722399537210173,0.0162478288870227,3.47635201543794e-07
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23477.Acetone,37986,0.0103645393113226,0.00231476946343206,0.00582759116299576,0.0149014874596495,7.61153342737447e-06
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23478.Creatinine,37582,-0.0137950488388729,0.00278866366647992,-0.0192608296251735,-0.00832926805257227,7.63651657248436e-07
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23479.Albumin,37985,0.0316105296622991,0.00237237054217416,0.0269606833996377,0.0362603759249604,2.99139637769141e-40
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23480.Glycoprotein Acetyls,37987,-0.0045792590144722,0.00255624342733262,-0.00958949613204414,0.00043097810309973,0.0732511777267768
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23481.Concentration of Chylomicrons and Extremely Large VLDL Particles,37987,-0.0182289080555444,0.00253973247753295,-0.023206783711509,-0.0132510323995798,7.47006674970554e-13
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23482.Total Lipids in Chylomicrons and Extremely Large VLDL,37987,-0.0172655222687873,0.0025398875577559,-0.0222437018819888,-0.0122873426555857,1.10716955634363e-11
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23483.Phospholipids in Chylomicrons and Extremely Large VLDL,37987,-0.0196148730578712,0.00250348957284354,-0.0245217126206445,-0.0147080334950979,5.03612107609411e-15
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23484.Cholesterol in Chylomicrons and Extremely Large VLDL,37987,-0.0159368967950299,0.00249823185393043,-0.0208334312287335,-0.0110403623613262,1.83721936382386e-10
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23485.Cholesteryl Esters in Chylomicrons and Extremely Large VLDL,37987,-0.0162922321274914,0.00247914693774914,-0.0211513601254797,-0.0114331041295031,5.15619797699176e-11
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23486.Free Cholesterol in Chylomicrons and Extremely Large VLDL,37987,-0.0148151684652784,0.00251319897918257,-0.0197410384644763,-0.00988929846608057,3.83732659112504e-09
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23487.Triglycerides in Chylomicrons and Extremely Large VLDL,37987,-0.0164807537951188,0.0025598554514549,-0.0214980704799704,-0.0114634371102672,1.25012314107359e-10
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,37987,-0.0180883383051474,0.00248938997454537,-0.0229675426552563,-0.0132091339550385,3.90054823064365e-13
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23489.Total Lipids in Very Large VLDL,37987,-0.0175018730606322,0.00249402365942517,-0.0223901594331055,-0.0126135866881588,2.36578737418167e-12
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23490.Phospholipids in Very Large VLDL,37987,-0.0180932290283341,0.00247730915195948,-0.0229487549661747,-0.0132377030904935,2.95863661984443e-13
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23491.Cholesterol in Very Large VLDL,37987,-0.0139488092927493,0.00240830156030252,-0.0186690803509422,-0.00922853823455633,7.11114101939058e-09
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23492.Cholesteryl Esters in Very Large VLDL,37987,-0.0113633958876913,0.00235888343514278,-0.0159868074205711,-0.0067399843548114,1.47107363996148e-06
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23493.Free Cholesterol in Very Large VLDL,37987,-0.0161073020263012,0.00245996778248619,-0.0209288388799741,-0.0112857651726283,6.05100009409395e-11
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23494.Triglycerides in Very Large VLDL,37987,-0.0181907505642063,0.00252170187614157,-0.0231332862414438,-0.0132482148869689,5.73544500484868e-13
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23495.Concentration of Large VLDL Particles,37987,-0.0155658968127687,0.00246905389316623,-0.0204052424433745,-0.0107265511821629,2.98298936504889e-10
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23496.Total Lipids in Large VLDL,37987,-0.0141228425975999,0.00246318116112831,-0.0189506776734114,-0.00929500752178843,1.00433099866795e-08
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23497.Phospholipids in Large VLDL,37987,-0.01807827395924,0.00244994222048841,-0.0228801607113973,-0.0132763872070827,1.68693472106966e-13
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23498.Cholesterol in Large VLDL,37987,-0.0125559592036196,0.00238306505020953,-0.0172267667020302,-0.00788515170520887,1.39404106995781e-07
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23499.Cholesteryl Esters in Large VLDL,37987,-0.00948044541373881,0.00232747029471602,-0.0140422871913822,-0.00491860363609542,4.6619100063213e-05
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23500.Free Cholesterol in Large VLDL,37987,-0.0154873327494014,0.00244196443619744,-0.0202735830443484,-0.0107010824544544,2.33765553233555e-10
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23501.Triglycerides in Large VLDL,37987,-0.0125803769894185,0.00250025472531963,-0.0174808762510449,-0.00767987772779199,4.92544090057329e-07
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23502.Concentration of Medium VLDL Particles,37987,0.00575361239809903,0.002344042166725,0.00115928975131802,0.01034793504488,0.014117870501492
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23503.Total Lipids in Medium VLDL,37987,0.00288511346683736,0.00236900851684772,-0.00175814322618417,0.0075283701598589,0.223299571330529
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23504.Phospholipids in Medium VLDL,37987,0.00691024513252597,0.00233789082681774,0.0023279791119632,0.0114925111530888,0.0031243702875118
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23505.Cholesterol in Medium VLDL,37987,0.0160078616082605,0.00235263620280529,0.0113966946507621,0.0206190285657589,1.05868376773704e-11
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23506.Cholesteryl Esters in Medium VLDL,37987,0.020103326976889,0.00239102740017143,0.015416913272553,0.024789740681225,4.59133744358171e-17
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23507.Free Cholesterol in Medium VLDL,37987,0.0101122917005158,0.00233115232596639,0.00554323314162165,0.0146813502594099,1.44896310698631e-05
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23508.Triglycerides in Medium VLDL,37987,-0.00710349453761694,0.00245596126104177,-0.0119171786092588,-0.00228981046597507,0.00382983464371841
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23509.Concentration of Small VLDL Particles,37987,-0.00645010765066142,0.00236129707075065,-0.0110782499093327,-0.00182196539199014,0.00631102230245596
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23510.Total Lipids in Small VLDL,37987,-0.00289901508812613,0.00234854662443059,-0.00750216647201008,0.00170413629575783,0.217080214441185
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23511.Phospholipids in Small VLDL,37987,0.00467322152567671,0.00231966806642511,0.000126672115483503,0.00921977093586993,0.0439654926228741
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23512.Cholesterol in Small VLDL,37987,0.00270832142559973,0.00229302598558882,-0.00178600950615436,0.00720265235735382,0.237578827862172
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23513.Cholesteryl Esters in Small VLDL,37987,-0.00161872930467278,0.00227967999759339,-0.00608690209995582,0.00284944349061025,0.477673797291907
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23514.Free Cholesterol in Small VLDL,37987,0.0103864024756304,0.00232232081868825,0.00583465367100148,0.0149381512802594,7.79676466661206e-06
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23515.Triglycerides in Small VLDL,37987,-0.0117471672004776,0.0024340985248603,-0.0165180003092038,-0.00697633409175139,1.40762488151888e-06
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23516.Concentration of Very Small VLDL Particles,37987,0.0120180981441715,0.00237268586118723,0.00736763385624455,0.0166685624320985,4.13368972077761e-07
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23517.Total Lipids in Very Small VLDL,37987,0.0132217096557697,0.00237119478080454,0.00857416788539279,0.0178692514261466,2.50866861308138e-08
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23518.Phospholipids in Very Small VLDL,37987,0.00684926063053818,0.00236861202848013,0.00220678105471712,0.0114917402063592,0.00383801876831873
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23519.Cholesterol in Very Small VLDL,37987,0.0231830853263974,0.00240829599716515,0.0184628251719537,0.0279033454808411,7.27248330655942e-22
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23520.Cholesteryl Esters in Very Small VLDL,37987,0.0269948877071043,0.00242413928227238,0.0222435747138504,0.0317462007003581,1.11809558921648e-28
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23521.Free Cholesterol in Very Small VLDL,37987,0.013738368072133,0.00237654750815441,0.0090803349561503,0.0183964011881156,7.59814023190721e-09
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23522.Triglycerides in Very Small VLDL,37987,-0.00576353911324725,0.00241871139784396,-0.0105042134530214,-0.0010228647734731,0.0171907356967251
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23523.Concentration of IDL Particles,37987,0.0230890323425923,0.00237825432434021,0.0184276538668855,0.0277504108182991,3.2807171987416e-22
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23524.Total Lipids in IDL,37987,0.0396177521264003,0.00242900364549439,0.0348569049812313,0.0443785992715693,3.06005888503764e-59
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23525.Phospholipids in IDL,37987,0.0359778311197908,0.00243925300217855,0.0311968952355209,0.0407587670040608,7.41641629294802e-49
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23526.Cholesterol in IDL,37987,0.0422414507941216,0.0024306513867025,0.0374773740761847,0.0470055275120585,6.36760747225518e-67
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23527.Cholesteryl Esters in IDL,37987,0.0427264461068837,0.00242538482316595,0.0379726918534784,0.047480200360289,1.07616900497616e-68
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23528.Free Cholesterol in IDL,37987,0.0397654392586819,0.00244315467209333,0.034976856101379,0.0445540224159848,5.2810661218117e-59
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23529.Triglycerides in IDL,37987,0.00383908099132196,0.0024526658516097,-0.000968144077833045,0.00864630606047696,0.11754330634244
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23530.Concentration of Large LDL Particles,37987,0.017257113751785,0.0023591701496109,0.0126331402585476,0.0218810872450223,2.72037893024246e-13
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23531.Total Lipids in Large LDL,37987,0.0347521152469278,0.00237201987625456,0.0301029562894689,0.0394012742043868,3.11242700848872e-48
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23532.Phospholipids in Large LDL,37987,0.0331487355196338,0.00236304868415136,0.0285171600986971,0.0377803109405704,2.15059529214379e-44
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23533.Cholesterol in Large LDL,37987,0.036315239309386,0.00237780188727299,0.0316547476103309,0.040975731008441,3.17112648746863e-52
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23534.Cholesteryl Esters in Large LDL,37987,0.0350625640401977,0.00236875232878291,0.0304198094757832,0.0397053186046122,3.43984489401498e-49
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23535.Free Cholesterol in Large LDL,37987,0.0387401288629719,0.00240140164502133,0.0340333816387301,0.0434468760872137,5.25250749630813e-58
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23536.Triglycerides in Large LDL,37987,0.00742011717791464,0.00248651468128903,0.00254654840258813,0.0122936859532412,0.00284880835754515
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23537.Concentration of Medium LDL Particles,37987,0.0146805883651383,0.00234083087757842,0.0100925598450846,0.019268616885192,3.683914310237e-10
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23538.Total Lipids in Medium LDL,37987,0.0210165164169516,0.00234798862721836,0.0164144587076036,0.0256185741262996,3.98105710571503e-19
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23539.Phospholipids in Medium LDL,37987,0.0199530699167832,0.00233148590948716,0.0153833575341884,0.024522782299378,1.26998185115993e-17
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23540.Cholesterol in Medium LDL,37987,0.0222985832363468,0.00234736940157771,0.0176977392092545,0.0268994272634391,2.46032879423591e-21
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23541.Cholesteryl Esters in Medium LDL,37987,0.0197984507941822,0.00235703373381438,0.015178664675906,0.0244182369124584,4.91710422338318e-17
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23542.Free Cholesterol in Medium LDL,37987,0.027973236796631,0.00234536591734593,0.023376319598633,0.032570153994629,1.24687985441039e-32
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23543.Triglycerides in Medium LDL,37987,0.00200833032581981,0.00252450377837388,-0.00293969707979299,0.00695635773143261,0.426316492118481
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23544.Concentration of Small LDL Particles,37987,0.00919409627570476,0.0023360377730094,0.00461546224060634,0.0137727303108032,8.33467498579189e-05
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23545.Total Lipids in Small LDL,37987,0.0164515641301539,0.00235542199815114,0.0118349370137777,0.0210681912465301,2.99112600522517e-12
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23546.Phospholipids in Small LDL,37987,0.0146764531304756,0.00234570509020273,0.0100788711536782,0.0192740351072729,4.04965424863282e-10
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23547.Cholesterol in Small LDL,37987,0.0185737855894675,0.00234763327785849,0.0139724243648648,0.0231751468140701,2.73504331799641e-15
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23548.Cholesteryl Esters in Small LDL,37987,0.0170931125150383,0.0023638091618535,0.0124600465578055,0.0217261784722712,5.04542928905765e-13
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23549.Free Cholesterol in Small LDL,37987,0.0211164601117542,0.00233447021168944,0.0165408984968428,0.0256920217266655,1.69007213917447e-19
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23550.Triglycerides in Small LDL,37987,-0.00569997766318537,0.00254468460476716,-0.010687559488529,-0.000712395837841741,0.025110044356446
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23551.Concentration of Very Large HDL Particles,37987,0.0407004468927272,0.00271469497341005,0.0353796447448435,0.0460212490406109,2.08155896868318e-50
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23552.Total Lipids in Very Large HDL,37987,0.0388825408290163,0.00273238867032173,0.0335270590351857,0.0442380226228469,1.26845560491728e-45
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23553.Phospholipids in Very Large HDL,37987,0.0364501603631678,0.00273408537287892,0.0310913530323251,0.0418089676940104,2.71551880522962e-40
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23554.Cholesterol in Very Large HDL,37987,0.0416063197219524,0.00271392868668739,0.0362870194960451,0.0469256199478597,1.31944915559376e-52
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23555.Cholesteryl Esters in Very Large HDL,37987,0.0472904971406142,0.00275238699074351,0.0418958186387569,0.0526851756424714,1.80081766144934e-65
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23556.Free Cholesterol in Very Large HDL,37987,0.0208708918064072,0.00254089630283398,0.0158907350528526,0.0258510485599618,2.33239490490348e-16
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23557.Triglycerides in Very Large HDL,37987,0.00612028923808016,0.00246315398103986,0.00129250743524203,0.0109480710409183,0.0129767183312971
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23558.Concentration of Large HDL Particles,37987,0.0679290151216213,0.00284146874910727,0.062359736373371,0.0734982938698715,9.50868939126455e-124
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23559.Total Lipids in Large HDL,37987,0.0677574924396532,0.00282580502083305,0.0622189145988204,0.073296070280486,1.82167734679324e-124
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23560.Phospholipids in Large HDL,37987,0.0679931924376908,0.00278633176670174,0.0625319821749554,0.0734544027004262,9.56177414548089e-129
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23561.Cholesterol in Large HDL,37987,0.0663656284028675,0.00283023555617808,0.0608183667127585,0.0719128900929766,3.18817283033387e-119
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23562.Cholesteryl Esters in Large HDL,37987,0.0663483529847447,0.00282172528847546,0.0608177714193328,0.0718789345501566,7.40325677689535e-120
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23563.Free Cholesterol in Large HDL,37987,0.0646081703078156,0.00282905266609146,0.0590632270822763,0.0701531135333549,2.66589915416011e-113
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23564.Triglycerides in Large HDL,37987,0.0179884755396532,0.00242392580025646,0.0132375809711505,0.0227393701081559,1.22966522806239e-13
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23565.Concentration of Medium HDL Particles,37987,0.0784526424965792,0.00250003675230885,0.0735525704620539,0.0833527145311046,1.01636059812727e-208
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23566.Total Lipids in Medium HDL,37987,0.0764578311194198,0.002479798979691,0.0715974251192254,0.0813182371196141,8.4614313668891e-202
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23567.Phospholipids in Medium HDL,37987,0.0736180714438334,0.00246773183164099,0.068781317053817,0.0784548258338497,1.88435084855882e-189
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23568.Cholesterol in Medium HDL,37987,0.0802757125140521,0.00250788007231544,0.0753602675723139,0.0851911574557904,8.74530698022993e-217
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23569.Cholesteryl Esters in Medium HDL,37987,0.0794571039126069,0.00249635512273598,0.0745642478720444,0.0843499599531695,1.84692022483779e-214
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23570.Free Cholesterol in Medium HDL,37987,0.080701040330029,0.0025400048309144,0.0757226308614368,0.0856794497986212,1.00647531000062e-213
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23571.Triglycerides in Medium HDL,37987,0.00638230732082844,0.0023482932771338,0.00177965249764619,0.0109849621440107,0.00657913811380815
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23572.Concentration of Small HDL Particles,37987,0.051333937508702,0.00228224415830004,0.0468607389584339,0.0558071360589701,5.01808902679998e-110
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23573.Total Lipids in Small HDL,37987,0.0511853805328146,0.00230729246312071,0.046663087305098,0.0557076737605312,3.92138318017938e-107
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23574.Phospholipids in Small HDL,37987,0.0534521543852319,0.00232827696302108,0.0488887315377106,0.0580155772327533,1.86521789842432e-114
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23575.Cholesterol in Small HDL,37987,0.0549372075485224,0.0022815592425982,0.0504653514330299,0.0594090636640149,1.78272609044408e-125
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23576.Cholesteryl Esters in Small HDL,37987,0.0510161504538147,0.00226146060696918,0.0465836876641551,0.0554486132434743,1.18893875536047e-110
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23577.Free Cholesterol in Small HDL,37987,0.0593439961016717,0.00236137934421182,0.0547156925870165,0.0639722996163269,2.9553385034045e-136
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23578.Triglycerides in Small HDL,37987,-0.0139861409541741,0.0024244856913346,-0.0187381329091899,-0.00923414899915825,8.16303932497853e-09
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,37243,-0.0127732853439619,0.00221215453738516,-0.0171091082372368,-0.00843746245068699,7.91456700553064e-09
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,37243,0.00526736902176136,0.00231005059272469,0.000739669860020967,0.00979506818350175,0.0226124237461029
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,37243,0.00194313767801376,0.00225486463051094,-0.00247639699778768,0.0063626723538152,0.388839286307107
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,37243,0.00886739222822515,0.00235591428491505,0.00424980022979165,0.0134849842266586,0.000168041287097073
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,37243,0.000819841102688731,0.00224076347954941,-0.00357205531722811,0.00521173752260557,0.714463814912863
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,37782,-0.0108903459492229,0.00217402543322671,-0.0151514357983472,-0.00662925610009853,5.53276562209784e-07
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,37782,0.0145274253772128,0.00247587237454164,0.00967471552311122,0.0193801352313145,4.52650634105263e-09
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23586.Cholesteryl Esters to Total Lipids in Very Large VLDL percentage,37782,0.0153410743289875,0.00248246184599916,0.0104754491108291,0.0202066995471458,6.60599424633113e-10
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,37782,0.00907589518352563,0.00234069836506188,0.00448812638800435,0.0136636639790469,0.000106072093361849
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,37782,-0.00937379912161252,0.00237498750788099,-0.0140287746370592,-0.00471882360616578,7.95814107890185e-05
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,37982,-0.0271520494786946,0.00231301132842589,-0.0316855516824094,-0.0226185472749799,1.14773119932627e-31
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,37982,0.0032716799400421,0.00228044084830873,-0.001197984122643,0.00774134400272721,0.151404286291766
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23591.Cholesteryl Esters to Total Lipids in Large VLDL percentage,37982,0.00989884370233467,0.002393409583021,0.00520776091961351,0.0145899264850558,3.55739635266198e-05
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,37982,-0.0117642897195677,0.00219048502930745,-0.0160576403770103,-0.00747093906212513,7.97584844566338e-08
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,37982,0.00902086869660602,0.00215140549827681,0.00480411391998348,0.0132376234732286,2.77026769069635e-05
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,37987,0.0214883321794337,0.00240871923573443,0.0167672424773942,0.0262094218814731,5.20436218899083e-19
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,37987,0.0265600812397779,0.00252080992308007,0.021619293790541,0.0315008686890148,7.3974477280533e-26
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,37987,0.026530582201499,0.00254210172310677,0.0215480628242097,0.0315131015787883,2.10958108182757e-25
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,37987,0.0252863357570097,0.00246092286186062,0.0204629269477628,0.0301097445662565,1.12374929503009e-24
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,37987,-0.0258741436811394,0.00250128052911383,-0.0307766535182025,-0.0209716338440763,5.49963695973334e-25
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,37987,0.0306273655798759,0.00245316912554758,0.0258191540938027,0.0354355770659492,1.41848346827176e-35
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,37987,0.0144459612308103,0.00240156012704712,0.0097389033817979,0.0191530190798226,1.84251686794893e-09
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23601.Cholesteryl Esters to Total Lipids in Small VLDL percentage,37987,0.000475977527848011,0.00233483671016667,-0.00410030242407866,0.00505225747977468,0.838466733249722
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,37987,0.0316324116759527,0.00246043209572875,0.0268099647683244,0.0364548585835811,1.31331425480977e-37
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,37987,-0.0196892437308087,0.00242102365872265,-0.0244344501019051,-0.0149440373597123,4.56481097190408e-16
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23604.Phospholipids to Total Lipids in Very Small VLDL percentage,37987,-0.0542336406098291,0.00242620346644684,-0.0589889994040649,-0.0494782818155933,1.02918820441669e-108
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23605.Cholesterol to Total Lipids in Very Small VLDL percentage,37987,0.0374332446022659,0.00254921322075141,0.0324367866895931,0.0424297025149387,1.91788784156117e-48
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23606.Cholesteryl Esters to Total Lipids in Very Small VLDL percentage,37987,0.0408313337611287,0.00256305849760725,0.0358077391058185,0.0458549284164389,1.26791585640393e-56
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23607.Free Cholesterol to Total Lipids in Very Small VLDL percentage,37987,0.00554951900650763,0.00249946044491293,0.000650576534478289,0.010448461478537,0.0264158041763132
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23608.Triglycerides to Total Lipids in Very Small VLDL percentage,37987,-0.0280650542316739,0.00255157477003223,-0.033066140780937,-0.0230639676824107,5.07144729687094e-28
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23609.Phospholipids to Total Lipids in IDL percentage,37987,-0.0301606565967061,0.00229735804501021,-0.0346634783649261,-0.0256578348284861,3.92494786289301e-39
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,37987,0.0386494646705527,0.00243233467208864,0.0338820887132589,0.0434168406278464,2.40556051369025e-56
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23611.Cholesteryl Esters to Total Lipids in IDL percentage,37987,0.0380075595174984,0.00242786495712438,0.0332489442015346,0.0427661748334622,9.31327395552026e-55
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,37987,0.0139480064749059,0.00249441927535339,0.00905894469521326,0.0188370682545986,2.29228852156034e-08
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,37987,-0.0355019848637555,0.00251315835213137,-0.040427775233933,-0.030576194493578,5.44698996264182e-45
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23614.Phospholipids to Total Lipids in Large LDL percentage,37987,-0.015668209573012,0.00230394267014067,-0.0201839372064877,-0.0111524819395363,1.08550686155055e-11
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23615.Cholesterol to Total Lipids in Large LDL percentage,37987,0.0428319207661134,0.00251066224573599,0.0379110227644708,0.0477528187677559,1.39192166416919e-64
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23616.Cholesteryl Esters to Total Lipids in Large LDL percentage,37987,0.0233151604853199,0.00232102228010045,0.018765956816323,0.0278643641543167,1.1671792202086e-23
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23617.Free Cholesterol to Total Lipids in Large LDL percentage,37987,0.0283478072597933,0.00252016893731063,0.0234082761426645,0.0332873383769221,3.17948270066788e-29
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23618.Triglycerides to Total Lipids in Large LDL percentage,37987,-0.0322865577811222,0.0025061071692079,-0.0371985278327697,-0.0273745877294747,9.33315581268872e-38
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23619.Phospholipids to Total Lipids in Medium LDL percentage,37987,-0.0118154175001495,0.00227659796567336,-0.0162775495128693,-0.00735328548742973,2.13399711467151e-07
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23620.Cholesterol to Total Lipids in Medium LDL percentage,37987,0.0292820650536204,0.00232922782317325,0.0247167785202008,0.03384735158704,4.81110503381481e-36
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23621.Cholesteryl Esters to Total Lipids in Medium LDL percentage,37987,0.00300066069521098,0.00237640145159333,-0.00165708614991195,0.00765840754033391,0.20672200771764
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23622.Free Cholesterol to Total Lipids in Medium LDL percentage,37987,0.0244875308729396,0.00257268616493751,0.019445065989662,0.0295299957562171,2.05447001992545e-21
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23623.Triglycerides to Total Lipids in Medium LDL percentage,37987,-0.0244683718762369,0.00242397430816578,-0.0292193615202418,-0.019717382232232,7.11067826637689e-24
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23624.Phospholipids to Total Lipids in Small LDL percentage,37987,-0.0110968395640282,0.00232534191845563,-0.0156545097242013,-0.0065391694038552,1.84190415368684e-06
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23625.Cholesterol to Total Lipids in Small LDL percentage,37987,0.0286079681959665,0.00234372723748106,0.0240142628105036,0.0332016735814294,4.3517110814035e-34
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23626.Cholesteryl Esters to Total Lipids in Small LDL percentage,37987,0.0117928214471851,0.00234934111201831,0.0071881128676292,0.016397530026741,5.24292020952233e-07
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23627.Free Cholesterol to Total Lipids in Small LDL percentage,37987,0.0166902289640259,0.00251640559802625,0.0117580739918945,0.0216223839361574,3.42426976713834e-11
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23628.Triglycerides to Total Lipids in Small LDL percentage,37987,-0.0224689453198127,0.00248157305505872,-0.0273328285077277,-0.0176050621318976,1.55981037352462e-19
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23629.Phospholipids to Total Lipids in Very Large HDL percentage,37985,0.0218382609988003,0.00267053777328805,0.0166040069631557,0.0270725150344449,3.15495698076306e-16
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23630.Cholesterol to Total Lipids in Very Large HDL percentage,37985,-0.00599045308286421,0.00267617204859064,-0.0112357502981019,-0.00074515586762655,0.0252085083636939
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23631.Cholesteryl Esters to Total Lipids in Very Large HDL percentage,37985,0.0386554253446879,0.00266100715158571,0.0334398513275799,0.0438709993617959,1.86949754513749e-47
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23632.Free Cholesterol to Total Lipids in Very Large HDL percentage,37985,-0.0614076578198919,0.00280105330833926,-0.0668977223042369,-0.055917593335547,1.02991148849413e-104
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23633.Triglycerides to Total Lipids in Very Large HDL percentage,37985,-0.0268955426722901,0.00266006078195255,-0.0321092618049171,-0.0216818235396631,6.01363625510367e-24
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23634.Phospholipids to Total Lipids in Large HDL percentage,37987,-0.0132338387156587,0.00276970116552224,-0.0186624530000823,-0.00780522443123514,1.78840061195791e-06
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23635.Cholesterol to Total Lipids in Large HDL percentage,37987,0.0311147508567278,0.0027526932554904,0.0257194720759666,0.036510029637489,1.7116500849272e-29
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23636.Cholesteryl Esters to Total Lipids in Large HDL percentage,37987,0.0300172130639469,0.00277798208289607,0.0245723681814706,0.0354620579464232,4.18642886577102e-27
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23637.Free Cholesterol to Total Lipids in Large HDL percentage,37987,0.0220667946074691,0.00267986200755791,0.0168142650726556,0.0273193241422826,1.97045978135408e-16
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23638.Triglycerides to Total Lipids in Large HDL percentage,37987,-0.0398449753110071,0.00266764366799959,-0.0450735569002863,-0.0346163937217279,4.78171243987659e-50
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23639.Phospholipids to Total Lipids in Medium HDL percentage,37987,-0.0476494522127515,0.00258753623793794,-0.0527210232391099,-0.0425778811863931,8.14721866247783e-75
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23640.Cholesterol to Total Lipids in Medium HDL percentage,37987,0.0431692897916031,0.00253228633356998,0.0382060085778059,0.0481325710054003,1.7148440216523e-64
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23641.Cholesteryl Esters to Total Lipids in Medium HDL percentage,37987,0.0316996086125916,0.00252578756306461,0.0267490649889849,0.0366501522361982,6.26938028981979e-36
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23642.Free Cholesterol to Total Lipids in Medium HDL percentage,37987,0.0703663846412523,0.00268830302440859,0.0650973107134115,0.0756354585690931,2.30505505507331e-147
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23643.Triglycerides to Total Lipids in Medium HDL percentage,37987,-0.0364534012195803,0.00247104542719914,-0.0412966502568906,-0.0316101521822699,7.13111604629638e-49
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23644.Phospholipids to Total Lipids in Small HDL percentage,37987,0.0168148937050383,0.00241163205123287,0.0120880948846218,0.0215416925254547,3.25997364026581e-12
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23645.Cholesterol to Total Lipids in Small HDL percentage,37987,0.0157594864057764,0.00242558393226268,0.0110053418985416,0.0205136309130112,8.46955374146665e-11
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23646.Cholesteryl Esters to Total Lipids in Small HDL percentage,37987,0.0102627820588817,0.00243570683982567,0.00548879665282334,0.01503676746494,2.53104617922786e-05
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23647.Free Cholesterol to Total Lipids in Small HDL percentage,37987,0.0206488273065196,0.00248453816285409,0.0157791325073256,0.0255185221057136,1.03932125698504e-16
PON1,Serum paraoxonase/arylesterase 1,NMR metabolomics,X23648.Triglycerides to Total Lipids in Small HDL percentage,37987,-0.0426605777884543,0.00246327267659282,-0.0474885922345762,-0.0378325633423324,1.76864132405968e-66
PON1,Serum paraoxonase/arylesterase 1,Working and living environment,X24003.Nitrogen dioxide air pollution; 2010,48311,0.00022107727630316,0.00200326381071005,-0.00370531979268854,0.00414747434529486,0.912125957984913
PON1,Serum paraoxonase/arylesterase 1,Working and living environment,X24004.Nitrogen oxides air pollution; 2010,48311,-0.000780084631476948,0.00196311422389478,-0.00462778851031071,0.00306761924735681,0.691097463725667
PON1,Serum paraoxonase/arylesterase 1,Working and living environment,X24005.Particulate matter air pollution (pm10); 2010,46603,-0.00213782686861812,0.00188452760209343,-0.00583150096872125,0.00155584723148501,0.256634901887314
PON1,Serum paraoxonase/arylesterase 1,Working and living environment,X24006.Particulate matter air pollution (pm2.5); 2010,46603,-0.000675536677379507,0.00206131836046359,-0.00471572066388814,0.00336464730912913,0.743125954709833
PON1,Serum paraoxonase/arylesterase 1,Working and living environment,X24007.Particulate matter air pollution (pm2.5) absorbance; 2010,46603,0.00177585797542704,0.0020165610918744,-0.00217660176464679,0.00572831771550087,0.378523969862199
PON1,Serum paraoxonase/arylesterase 1,Working and living environment,X24008.Particulate matter air pollution 2.5-10um; 2010,46603,-0.00106569444418136,0.00185113323157951,-0.00469391557807719,0.00256252668971447,0.564824903616662
PON1,Serum paraoxonase/arylesterase 1,Working and living environment,X24009.Traffic intensity on the nearest road,48311,0.0474711819821047,0.0999821695227038,-0.148493870282395,0.243436234246604,0.634936389371166
PON1,Serum paraoxonase/arylesterase 1,Working and living environment,X24010.Inverse distance to the nearest road,48311,-3.7508876443625e-05,0.00175636434235461,-0.00347998298745866,0.00340496523457141,0.982961869422699
PON1,Serum paraoxonase/arylesterase 1,Working and living environment,X24011.Traffic intensity on the nearest major road,48311,-0.00150105132805394,0.00175747167472791,-0.00494569581052064,0.00194359315441276,0.393059807594852
PON1,Serum paraoxonase/arylesterase 1,Working and living environment,X24012.Inverse distance to the nearest major road,48311,0.00154531830149751,0.00179243157575763,-0.00196784758698745,0.00505848418998247,0.388621804587253
PON1,Serum paraoxonase/arylesterase 1,Working and living environment,X24013.Total traffic load on major roads,48311,0.0816445898373052,0.0696370182073333,-0.054843965849068,0.218133145523678,0.241035818241363
PON1,Serum paraoxonase/arylesterase 1,Working and living environment,X24015.Sum of road length of major roads within 100m,48311,0.0863914029861955,0.0676173039239535,-0.0461385127047533,0.218921318677144,0.201384487492472
PON1,Serum paraoxonase/arylesterase 1,Working and living environment,X24016.Nitrogen dioxide air pollution; 2005,48311,0.000799803184996202,0.00199658395761586,-0.00311350137193088,0.00471310774192329,0.688728687737454
PON1,Serum paraoxonase/arylesterase 1,Working and living environment,X24017.Nitrogen dioxide air pollution; 2006,48311,0.00059669538451887,0.00199288009395086,-0.00330934959962482,0.00450274036866256,0.764627101814508
PON1,Serum paraoxonase/arylesterase 1,Working and living environment,X24018.Nitrogen dioxide air pollution; 2007,48311,0.00038401174100788,0.00197424854196801,-0.00348551540124942,0.00425353888326518,0.845777961877148
PON1,Serum paraoxonase/arylesterase 1,Working and living environment,X24019.Particulate matter air pollution (pm10); 2007,48253,-0.00246005055358496,0.00194092763747843,-0.00626426872304268,0.00134416761587277,0.205002813957371
PON1,Serum paraoxonase/arylesterase 1,Working and living environment,X24020.Average daytime sound level of noise pollution,48311,0.00153663609081938,0.00177096325602137,-0.0019344518909825,0.00500772407262126,0.38557619487761
PON1,Serum paraoxonase/arylesterase 1,Working and living environment,X24021.Average evening sound level of noise pollution,48311,0.00152100117357674,0.00177101579382613,-0.00195018978232248,0.00499219212947596,0.390443041583105
PON1,Serum paraoxonase/arylesterase 1,Working and living environment,X24022.Average night-time sound level of noise pollution,48311,0.00153454678783527,0.00177092884213834,-0.00193647374275586,0.00500556731842641,0.386213304400759
PON1,Serum paraoxonase/arylesterase 1,Working and living environment,X24023.Average 16-hour sound level of noise pollution,48311,0.00152909044347289,0.00177096612175236,-0.00194200315516173,0.00500018404210751,0.387914374198257
PON1,Serum paraoxonase/arylesterase 1,Working and living environment,X24024.Average 24-hour sound level of noise pollution,48311,0.00153294136750426,0.00177101569559691,-0.00193824939586569,0.00500413213087422,0.386733690538575
PON1,Serum paraoxonase/arylesterase 1,Working and living environment,"X24500.Greenspace percentage, buffer 1000m",45602,-0.00193590239910479,0.00206127905965436,-0.00597600935602733,0.00210420455781776,0.347651468705608
PON1,Serum paraoxonase/arylesterase 1,Working and living environment,"X24501.Domestic garden percentage, buffer 1000m",45602,-0.00225089893651036,0.00188130335779435,-0.00593825351778729,0.00143645564476658,0.231531605394396
PON1,Serum paraoxonase/arylesterase 1,Working and living environment,"X24502.Water percentage, buffer 1000m",45602,-0.000534109155159483,0.00184028804860419,-0.0041410737304237,0.00307285542010473,0.771642153309848
PON1,Serum paraoxonase/arylesterase 1,Working and living environment,"X24503.Greenspace percentage, buffer 300m",45602,0.000742405791595941,0.00194177823862695,-0.00306347955611287,0.00454829113930476,0.702218262947165
PON1,Serum paraoxonase/arylesterase 1,Working and living environment,"X24504.Domestic garden percentage, buffer 300m",45602,-0.00354697470164019,0.00189750399408041,-0.00726608253003779,0.000172133126757415,0.0615970593649295
PON1,Serum paraoxonase/arylesterase 1,Working and living environment,"X24505.Water percentage, buffer 300m",45602,0.00115356159157354,0.00185595576827579,-0.00248411171424701,0.00479123489739408,0.534247240872431
PON1,Serum paraoxonase/arylesterase 1,Working and living environment,"X24506.Natural environment percentage, buffer 1000m",48462,-0.000508482671761961,0.00195065397321894,-0.00433176445927109,0.00331479911574716,0.794346984608919
PON1,Serum paraoxonase/arylesterase 1,Working and living environment,"X24507.Natural environment percentage, buffer 300m",48462,0.000809599196076466,0.00184144724397096,-0.00279963740210662,0.00441883579425956,0.660191857996511
PON1,Serum paraoxonase/arylesterase 1,Working and living environment,X24508.Distance (Euclidean) to coast,48462,-2.62201116873209e-06,0.00175352240323223,-0.00343952592150391,0.00343428189916644,0.998806950134665
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X2684.Years since last breast cancer screening  or  mammogram,34278,-0.132721993700586,0.074075689003953,-0.277910344148334,0.0124663567471616,0.0732105392579757
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X2704.Years since last cervical smear test,42831,0.0239135272962982,0.0536457916304609,-0.0812322242994052,0.129059278892002,0.655770762870674
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X2714.Age when periods started (menarche),47873,-0.121090646283608,0.0453842078926642,-0.210043693753229,-0.0321375988139858,0.0076328848041096
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X2734.Number of live births,48606,-0.16081772437721,0.0443485954250602,-0.247740971410328,-0.073894477344092,0.0002881931102272
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X2744.Birth weight of first child,43637,0.0542380461806524,0.0488415533280123,-0.0414913983422517,0.149967490703556,0.266801950662924
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X2754.Age at first live birth,40771,0.0033611651949481,0.00222911800782713,-0.00100790610039308,0.00773023649028928,0.131613473389533
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X2764.Age at last live birth,40722,0.000732468504604636,0.00214362080719226,-0.00346902827749219,0.00493396528670146,0.732583446383167
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X2794.Age started oral contraceptive pill,42958,-0.00744614174589457,0.00242863074293346,-0.0122062580020442,-0.00268602548974498,0.00217267988381028
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X2804.Age when last used oral contraceptive pill,41234,0.00399503177395473,0.00211820179296064,-0.000156643740248124,0.00814670728815759,0.0593056428565177
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X2867.Age started smoking in former smokers,29381,0.00490910204386511,0.00407064405933412,-0.00306936031242976,0.01288756440016,0.227884344613609
PON1,Serum paraoxonase/arylesterase 1,Mental health,"X28735.Feeling anxious, nervous or on edge over the last 2 weeks",33926,-0.237395502821532,0.0838436167114281,-0.401728991575931,-0.0730620140671334,0.0046441232693468
PON1,Serum paraoxonase/arylesterase 1,Mental health,X28736.Not being able to stop or control worrying over the last 2 weeks,33919,-0.236362139599171,0.0901661065219269,-0.413087708382147,-0.0596365708161942,0.00877074955556207
PON1,Serum paraoxonase/arylesterase 1,Mental health,X28737.Little interest or pleasure in doing things over the last 2 weeks,33948,-0.27767223751414,0.0980057882489299,-0.469763582482043,-0.0855808925462374,0.00461783929861295
PON1,Serum paraoxonase/arylesterase 1,Mental health,"X28738.Feeling down, depressed or hopeless over the last 2 weeks",33906,-0.316818512599166,0.093426889233589,-0.499935215497,-0.133701809701331,0.000699016739881698
PON1,Serum paraoxonase/arylesterase 1,Mental health,X28739.Difficulty with standing for long periods,33965,-0.275065031053834,0.0825895519007745,-0.436940552779352,-0.113189509328316,0.000870182067586267
PON1,Serum paraoxonase/arylesterase 1,Mental health,X28740.Difficulty with taking care of household responsibilities,33989,-0.402883871560346,0.0890544102731143,-0.57743051569565,-0.228337227425043,6.14100268291627e-06
PON1,Serum paraoxonase/arylesterase 1,Mental health,X28741.Difficulty learning a new task,33891,-0.293750948004727,0.0995707274741843,-0.488909573854128,-0.0985923221553261,0.0031837544114076
PON1,Serum paraoxonase/arylesterase 1,Mental health,X28742.Difficulty with joining in community activities,33649,-0.27424123324383,0.105430913705455,-0.480885824106521,-0.0675966423811385,0.00930616385994772
PON1,Serum paraoxonase/arylesterase 1,Mental health,X28743.Difficulty with being emotionally affected by health problems,33921,-0.368425280403065,0.088444113797935,-0.541775743447017,-0.195074817359112,3.13253703158933e-05
PON1,Serum paraoxonase/arylesterase 1,Mental health,X28744.Difficulty with concentrating on doing something for ten minutes,33979,-0.264999193539141,0.12851794342173,-0.516894362645731,-0.0131040244325513,0.0392383624005787
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X2887.Number of cigarettes previously smoked daily,29361,-0.0895692123879976,0.0984057606957761,-0.282444503351719,0.103306078575724,0.362760192890909
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X2897.Age stopped smoking,29390,-0.00721168480220059,0.0041683952778306,-0.0153817395467486,0.000958369942347393,0.0836772734806094
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29001#0.Mental health conditions experienced by first degree blood relatives_None of the above,33011,0.00868863570166982,0.00569032852190583,-0.0024644082012656,0.0198416796046052,0.126819636525633
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29001#1.Mental health conditions experienced by first degree blood relatives_Depression,33011,-0.0177859676124081,0.00606129505434454,-0.0296661059189234,-0.00590582930589276,0.00335133645622697
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29001#3.Mental health conditions experienced by first degree blood relatives_Schizophrenia,33011,0.00224573221618312,0.0204309308222021,-0.037798892195333,0.0422903566276993,0.912476783717262
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29001#4.Mental health conditions experienced by first degree blood relatives_Any other type of psychosis or psychotic illness,33011,0.0181190299802717,0.0219631847923327,-0.0249288122127004,0.0611668721732438,0.409410026193749
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29001#5.Mental health conditions experienced by first degree blood relatives_A personality disorder,33011,0.00253179890954566,0.0223962011959334,-0.0413647554344838,0.0464283532535751,0.909996810016679
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29001#7.Mental health conditions experienced by first degree blood relatives_Attention deficit or attention deficit and hyperactivity disorder,33011,-0.0211887224223232,0.0182574159687898,-0.0569732577211512,0.0145958128765047,0.245855572510029
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29001#8.Mental health conditions experienced by first degree blood relatives_An anxiety disorder,33011,-0.00576306698381508,0.00860853342572301,-0.0226357924982322,0.011109658530602,0.503220280310849
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29001#9.Mental health conditions experienced by first degree blood relatives_An eating disorder,33011,-0.00391725891260949,0.0149080984552795,-0.0331371318849572,0.0253026140597383,0.792741532111417
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29002.Recent lack of interest or pleasure in doing things,32951,-0.33170182080915,0.0990940047705291,-0.525926070159387,-0.137477571458913,0.00081943877961751
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29003.Recent feelings of depression,32938,-0.353637777997961,0.0949860348633922,-0.539810406330209,-0.167465149665712,0.000198104652321624
PON1,Serum paraoxonase/arylesterase 1,Mental health,"X29004.Trouble falling or staying asleep, or sleeping too much",32956,-0.139044238229592,0.0791822899735746,-0.294241526577798,0.0161530501186143,0.079124116152077
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29005.Recent feelings of tiredness or low energy,32964,-0.330561377809101,0.0803506953026935,-0.48804874060238,-0.173074015015822,3.92554473700027e-05
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29006.Recent poor appetite or overeating,32969,-0.411226587459344,0.101109520087512,-0.609401246830868,-0.21305192808782,4.80226541412884e-05
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29007.Recent feelings of inadequacy,32925,-0.291382280746648,0.102918502198978,-0.493102545056645,-0.0896620164366506,0.00464838253276032
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29008.Recent trouble concentrating on things,32967,-0.180173679385156,0.105450695144288,-0.386857041867961,0.0265096830976482,0.0875604282118962
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29009.Recent changes in speed or amount of moving or speaking,32956,-0.496525779803355,0.18226685209959,-0.853768809918552,-0.139282749688159,0.00645951667259908
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29010.Recent thoughts of suicide or self-harm,32898,-0.685189591053752,0.196480480884676,-1.07029133358772,-0.300087848519786,0.000490377114950067
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29038#0.Substances taken for depression_None of options listed,32048,0.0163132048146493,0.0113498994588415,-0.00593259812468001,0.0385590077539787,0.150674100598073
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29038#1.Substances taken for depression_Drugs or alcohol (more than once),32048,0.0124041608399439,0.0223940713440536,-0.0314882189944011,0.0562965406742889,0.579661000397291
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),32048,-0.0008777593019176,0.0106235133990581,-0.0216998455640715,0.0199443269602363,0.934152534833663
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29038#3.Substances taken for depression_Unprescribed medication (more than once),32048,0.0193257022834859,0.0315740815603367,-0.0425594975747741,0.0812109021417458,0.540506534477031
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29039#1.Use of specific medications_Citalopram (sometimes called Cipramil),32048,-0.0158355104607475,0.0196533281256832,-0.0543560335870865,0.0226850126655915,0.420416891588121
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29039#2.Use of specific medications_Fluoxetine (Prozac or Oxactin),32048,-0.00448309705019458,0.020483779315308,-0.0446313045081982,0.0356651104078091,0.826764335716332
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29039#3.Use of specific medications_Sertraline (Lustral),32048,-0.00289555085782241,0.0244933009836732,-0.0509024207858219,0.045111319070177,0.905897995555628
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29039#5.Use of specific medications_Amitriptyline (Elavil),32048,0.0360464335714488,0.0265518981569712,-0.0159952868162148,0.0880881539591124,0.174636034467171
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29039#7.Use of specific medications_Other antidepressant(s),32048,-0.00424875299300455,0.0202153851785687,-0.0438709079429993,0.0353734019569902,0.833537329646704
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29047#0.Activities undertaken to treat depression_None of options listed,32048,0.0132028560000246,0.0113749898828953,-0.00909212417045024,0.0354978361704995,0.245803786627567
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29051#0.Manifestations of mania or irritability_None of options listed,32048,0.0056729084857149,0.0172071774037832,-0.0280531592257002,0.03939897619713,0.741648827232704
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29051#1.Manifestations of mania or irritability_More active than usual,32048,0.00892564843957976,0.0268406958283575,-0.0436821153840009,0.0615334122631605,0.73948949514162
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29051#2.Manifestations of mania or irritability_More confident than usual,32048,-0.0463545308919975,0.0354347956434968,-0.115806730353251,0.0230976685692562,0.190857207489979
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29051#3.Manifestations of mania or irritability_Easily distracted,32048,0.00719167891178185,0.0234927472511885,-0.0388541057005477,0.0532374635241114,0.759519105906783
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29051#4.Manifestations of mania or irritability_More creative or had more ideas than usual,32048,-0.0216053388163636,0.0394134013079782,-0.0988556053800009,0.0556449277472737,0.583589639645196
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29051#5.Manifestations of mania or irritability_Neded less sleep than usual,32048,0.0311191673747875,0.0363857094096694,-0.0401968230681645,0.102435157817739,0.392435333789212
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29051#6.Manifestations of mania or irritability_Thoughts were racing,32048,0.0262145741203911,0.0197176780712079,-0.0124320748991764,0.0648612231399585,0.183724309557351
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29051#7.Manifestations of mania or irritability_More restless than usual,32048,0.0149042205235962,0.0191706376573507,-0.0226702292848112,0.0524786703320035,0.436917280015629
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29051#8.Manifestations of mania or irritability_More talkative than usual,32048,-0.0200675574427928,0.0268542904247549,-0.0727019666753124,0.0325668517897269,0.454920315962675
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29058.Recent feelings or nervousness or anxiety,32827,-0.263099600994971,0.0893499181371029,-0.438225440543693,-0.0879737614462494,0.00324263553740287
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29059.Recent inability to stop or control worrying,32839,-0.319175501093813,0.0907743997977159,-0.497093324697336,-0.14125767749029,0.000440184398699433
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29060.Recent worrying too much about different things,32830,-0.233819083661674,0.0862145688667095,-0.402799638640424,-0.0648385286829232,0.00670029864292562
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29061.Recent trouble relaxing,32838,-0.223291183513727,0.0903400050954581,-0.400357593500825,-0.046224773526629,0.0134678634681372
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29062.Recent restlessness,32846,-0.290369053837703,0.129757246532952,-0.544693257042289,-0.0360448506331178,0.0252610949080383
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29063.Recent easy annoyance or irritability,32813,-0.0575500512750914,0.0952557402826838,-0.244251302229152,0.129151199678969,0.545751272888061
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29064.Recent feelings of foreboding,32805,-0.192508977553334,0.103113549602759,-0.394611534774742,0.00959357966807489,0.0619420445003207
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29065#1.Symptoms of panic attack_Heart was pounding or racing,32048,0.0188702909364896,0.0113168790121777,-0.00331079192737862,0.0410513738003579,0.0954668647668204
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29065#11.Symptoms of panic attack_Felt like things weren't real or detached from self,32048,-0.0109462031416756,0.0194932819781416,-0.0491530358188331,0.0272606295354819,0.57444793877182
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29065#12.Symptoms of panic attack_Afraid of losing control or 'going crazy',32048,0.0247756319813096,0.0246532184033241,-0.0235446760892056,0.0730959400518248,0.314945513024788
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29065#13.Symptoms of panic attack_Afraid I was going to die,32048,0.0489363573029656,0.0272425701150205,-0.00445908012247451,0.102331794728406,0.0724834535904899
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29065#2.Symptoms of panic attack_Sweating,32048,0.0155341230114264,0.0183903204177766,-0.0205109050074157,0.0515791510302685,0.398310448233404
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29065#3.Symptoms of panic attack_Trembling or shaking,32048,-0.00013139261877706,0.0184062992527996,-0.0362077391542644,0.0359449539167102,0.994304569336732
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29065#6.Symptoms of panic attack_Pain or discomfort in chest,32048,0.0248706147442687,0.0190192065070151,-0.0124070300094809,0.0621482594980183,0.19102896007208
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29065#7.Symptoms of panic attack_Nauseous or felt sick in the stomach,32048,0.00844353413261571,0.0169167688207383,-0.0247133327560313,0.0416004010212627,0.617707784116447
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29065#9.Symptoms of panic attack_Felt hot or cold,32048,0.025151544765177,0.0228714304228814,-0.0196764588636705,0.0699795483940245,0.27150089290003
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29076.Felt loved as a child,32808,0.0376677851565443,0.0842762765163787,-0.127513716815558,0.202849287128647,0.654918437039233
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29077.Physically abused by family as a child,32824,-0.194640632951116,0.116491478892863,-0.422963931581129,0.0336826656788959,0.0947872661311644
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29078.Felt hated by family member as a child,32804,-0.241515388949549,0.10825432280313,-0.453693861643683,-0.0293369162554152,0.0257075864698436
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29079.Sexually molested as a child,32715,-0.173798352241605,0.136916422803177,-0.442154540935831,0.0945578364526213,0.204342934874738
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29080.Someone to take to doctor when needed as a child,32787,0.133079267335983,0.117433076486043,-0.0970895625766609,0.363248097248628,0.257148204952706
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29081.Stopped from seeing friends or family by partner or ex-partner as an adult,32801,-0.0346083926530192,0.147067135646252,-0.322859978519673,0.253643193213634,0.813963220252494
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29082.Belittlement by partner or ex-partner as an adult,32735,-0.261422481594154,0.108938514000512,-0.474941969035158,-0.0479029941531492,0.0164293379777897
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29083.Physical violence by partner or ex-partner as an adult,32802,-0.149556770518012,0.121929075126102,-0.388537757765171,0.0894242167291471,0.220011978980349
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29084.Sexual interference by partner or ex-partner without consent as an adult,32764,-0.154167672495031,0.15135442240113,-0.450822340401245,0.142486995411183,0.308428648338869
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29085.Sexual intercourse by partner or ex-partner without consent as an adult,32772,-0.258366553875728,0.149179547807663,-0.550758467578748,0.0340253598272913,0.0833254589061687
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29086.Experienced a violent or sexual assault,32803,-0.156711455611608,0.140833970784398,-0.432746038349028,0.119323127125813,0.265852562170504
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29087.Experienced a life-threatening injury or illness,32815,-0.109130402562276,0.100599995172388,-0.306306393100158,0.0880455879756049,0.278043598958639
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29088.Experienced a marital separation or divorce,32818,-0.0388711999479156,0.0902734888738524,-0.215807238140666,0.138064838244835,0.666774881506383
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29089.Experienced the death of a spouse or partner,32824,-0.211633971696473,0.112106791283184,-0.431363282611514,0.00809533921856859,0.0590888340654995
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29090.Experienced the death of a close friend or family member due to suicide,32810,0.0447242757337479,0.115080068562499,-0.18083265864875,0.270281210116246,0.697555215512021
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X29091.Frequency of drinking alcohol,32820,0.756550164682237,0.076379743690984,0.606845867047909,0.906254462316566,5.29238941779916e-23
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X29092.Amount of alcohol drunk on a typical drinking day,31724,0.617445399520999,0.0961613677175177,0.428969118794664,0.805921680247333,1.43969296270356e-10
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X29093.Frequency of consuming six or more units of alcohol,31739,0.583278421319705,0.0988650425467249,0.389502937928124,0.777053904711286,3.80369025665184e-09
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29104.Ever used cannabis,32815,0.196374579932523,0.118094158253122,-0.0350899702435968,0.427839130108643,0.0963770536890657
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29108.Ever thought that life not worth living,32770,-0.216798535404453,0.0904124582599625,-0.394006953593979,-0.0395901172149261,0.0165120186187733
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29109.Ever contemplated self-harm,32798,-0.182443726212877,0.119507464323838,-0.416678356287599,0.0517909038618442,0.126890845161092
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29111.Ever self-harmed,32812,-0.128196261159028,0.1861080209932,-0.492967982305699,0.236575459987643,0.490951153918259
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X29132.Ever had recurrent episodes of excessive overeating or binge eating,32804,-0.444003089980075,0.124748036809533,-0.688509242126759,-0.199496937833391,0.000374053783448822
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X29136#1.Actions and feelings during periods of overeating or binge eating_Eaten much more rapidly than normal,32666,-0.0170902840175935,0.0238847130046077,-0.0639043215066245,0.0297237534714375,0.474300517915319
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X29136#2.Actions and feelings during periods of overeating or binge eating_Eaten until feeling uncomfortably full,32666,-0.0165294470952107,0.01876026254517,-0.053299561683744,0.0202406674933225,0.378295830385574
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X29136#3.Actions and feelings during periods of overeating or binge eating_Eaten large amounts of food when not physically hungry,32666,0.00564310396035108,0.0190523860910271,-0.0316995727780621,0.0429857806987643,0.767093365951705
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X29136#4.Actions and feelings during periods of overeating or binge eating_Eaten alone because of feeling embarrassed by overeating,32666,-0.0264029192628642,0.0246019013329435,-0.0746226458754335,0.021816807349705,0.28321002341648
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,X29149.Dependency of self-esteem on body shape or weight currently,32799,0.0290114097116197,0.0845299644184283,-0.1366673205485,0.194690139971739,0.731450188943158
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X29153.Pain or discomfort today,32810,-0.239389798317811,0.080914059795997,-0.397981355517965,-0.0807982411176566,0.00309937900560434
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29154.Anxiety or depression today,32810,-0.370989369689026,0.0962239017219586,-0.559588217064065,-0.182390522313988,0.000116369000959049
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29166.Frequency of confiding in someone close,32598,0.0485641366242379,0.0775585140458695,-0.103450550905666,0.200578824154142,0.531226729498436
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X29167#0.Sports and social activities attended in person at least once a week_None of the above,32781,-0.00816789914196861,0.00613979785901906,-0.020201902945646,0.00386610466170875,0.183449108631549
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X29167#1.Sports and social activities attended in person at least once a week_Sports club or gym or fitness class,32781,0.0140115717027684,0.00602080431834662,0.00221079523880904,0.0258123481667278,0.0199788591172482
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X29167#2.Sports and social activities attended in person at least once a week_Pub or social club,32781,0.0282827024704465,0.00884241900707913,0.0109515612165714,0.0456138437243215,0.00138649420333858
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X29167#3.Sports and social activities attended in person at least once a week_Religious group,32781,-0.0145148779075535,0.00764843651016491,-0.0295058134674768,0.000476057652369685,0.05776257657906
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X29167#4.Sports and social activities attended in person at least once a week_Adult education class,32781,0.000402410518977516,0.0112910130661515,-0.0217279750906795,0.0225327961286345,0.971570351054776
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X29167#5.Sports and social activities attended in person at least once a week_Other group activity,32781,0.0103176363151285,0.0059932161865714,-0.00142906741055139,0.0220643400408085,0.0851877454930831
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X29168#0.Sports and social activities attended virtually at least once a week_None of the above,32781,-0.00188158316101052,0.00659368830723828,-0.0148052122431975,0.0110420459211765,0.775374484742132
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X29168#1.Sports and social activities attended virtually at least once a week_Sports club or gym or fitness class,32781,0.00392494708726257,0.00922834743737913,-0.0141626138900005,0.0220125080645257,0.670618640875823
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X29168#2.Sports and social activities attended virtually at least once a week_Pub or social club,32781,0.0338251477030759,0.0195438816132628,-0.00448086025891927,0.072131155665071,0.0835372837292766
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X29168#3.Sports and social activities attended virtually at least once a week_Religious group,32781,0.00238099391803389,0.012728654174014,-0.0225671682630336,0.0273291560991014,0.851619878842674
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X29168#4.Sports and social activities attended virtually at least once a week_Adult education class,32781,0.0138383341133075,0.0177260389788879,-0.0209047022853127,0.0485813705119278,0.435013908396278
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X29168#5.Sports and social activities attended virtually at least once a week_Other group activity,32781,-0.00255583253737905,0.00933747092774271,-0.0208572755557548,0.0157456104809967,0.784308240535258
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29171.Frequency of feeling 'in tune' with people,32686,0.195486818631506,0.0975019756821125,0.00438294629456526,0.386590690968446,0.0450008149013107
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29172.Freuency of feeling that lacks companionship,32759,-0.200526568281741,0.0868426083752313,-0.370738080697194,-0.0303150558662876,0.0209635376065223
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29173.Frequency of feeling left out,32705,-0.186747802776706,0.0904797198082687,-0.364088053600913,-0.00940755195249904,0.0390513561975841
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29174.Frequency of feeling isolated from others,32732,-0.203262503834832,0.0939973371600789,-0.387497284668586,-0.0190277230010771,0.0306137224063605
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29175.Tendency to bounce back quickly after hard times,32798,0.10797707489835,0.0795181180927755,-0.0478784365634904,0.26383258636019,0.174534445007703
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29176.Ability to make it through stressful events,32798,-0.201784657115928,0.0774723004426407,-0.353630365983504,-0.049938948248352,0.00921436568830147
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29177.Quick recovery from stressful events,32798,0.138212162482588,0.0785189289171183,-0.0156849381949637,0.29210926316014,0.0784037539551318
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29178.Hard to snap back when something bad happens,32798,-0.235645195818724,0.0771061391453017,-0.386773228543515,-0.0845171630939321,0.0022493430726164
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29179.Comes through difficult times with little trouble,32798,0.107497407784445,0.0783616524824498,-0.0460914310811564,0.261086246650047,0.170159045909288
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29180.Tendency to take a long time to get over setbacks,32798,-0.207692856002643,0.0779046609803995,-0.360385991524226,-0.0549997204810604,0.00769104860052271
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29181.General happiness,32750,-0.213473465671558,0.0819848657163074,-0.37416380247552,-0.0527831288675952,0.00923566638721719
PON1,Serum paraoxonase/arylesterase 1,Mental health,X29182.Belief that own life is meaningful,32658,0.134948890713075,0.0809507584334242,-0.0237145958164369,0.293612377242586,0.0955428121261867
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X2926.Number of unsuccessful stop-smoking attempts,28986,0.0783549210013043,0.100188057469613,-0.118013671639137,0.274723513641746,0.434209317430737
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X2946.Father's age,29842,0.000176412986142875,0.00549006087002009,-0.0105841063190965,0.0109369322913823,0.974367051603311
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X2966.Age high blood pressure diagnosed,29589,0.00360674375442517,0.0044719090074665,-0.00515819790020917,0.0123716854090595,0.419972722956296
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30000.White blood cell (leukocyte) count,47826,-0.00565881197367131,0.00185218893885111,-0.0092891022938195,-0.00202852165352313,0.00225162065785278
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30010.Red blood cell (erythrocyte) count,47826,0.0105969919434348,0.00218062247405696,0.00632297189428319,0.0148710119925865,1.18374544658708e-06
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30020.Haemoglobin concentration,47826,0.0286643641211275,0.00236190875272143,0.0240350229657935,0.0332937052764615,8.59293387468652e-34
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30030.Haematocrit percentage,47826,0.0266658316761966,0.002293683792661,0.0221702114425811,0.0311614519098122,3.71412871164369e-31
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30040.Mean corpuscular volume,47826,0.0159832834608278,0.00181919962386568,0.0124176521980511,0.0195489147236045,1.65591348595313e-18
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30050.Mean corpuscular haemoglobin,47825,0.0151841826920135,0.00182428257583165,0.0116085888433834,0.0187597765406435,9.01224329618624e-17
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30060.Mean corpuscular haemoglobin concentration,47825,0.00338446236098229,0.00179043232361218,-0.000124784993297591,0.00689370971526217,0.0587296007539456
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30070.Red blood cell (erythrocyte) distribution width,47826,-0.0128141711364132,0.00172513614554496,-0.0161954379816813,-0.00943290429114503,1.14098261099397e-13
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30080.Platelet count,47826,0.00609474985943171,0.00182770355589159,0.00251245088988419,0.00967704882897923,0.000855399414531617
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30090.Platelet crit,47826,0.00452725909935611,0.00187548790863282,0.000851302798435781,0.00820321540027643,0.015789993592483
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30100.Mean platelet (thrombocyte) volume,47826,-0.0043326042432904,0.00176672949777128,-0.00779539405892212,-0.000869814427658683,0.0142006898620022
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30110.Platelet distribution width,47826,-0.00962970208784435,0.00177027436688315,-0.0130994398469353,-0.00615996432875338,5.39158739044096e-08
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30120.Lymphocyte count,47793,0.00347884227475293,0.00183676047404983,-0.000121208254384731,0.00707889280389059,0.0582360656207982
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30130.Monocyte count,47793,-0.00290009400379638,0.00186984859207403,-0.00656499724426148,0.000764809236668712,0.120920517507253
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30140.Neutrophill count,47793,-0.00724552495443942,0.00184161510018235,-0.0108550905507968,-0.00363595935808201,8.36698765544686e-05
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30150.Eosinophill count,47793,-0.00973602408572533,0.00181343769661991,-0.0132903619711004,-0.0061816862003503,8.00091304196127e-08
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30160.Basophill count,47793,-0.0226952206096552,0.0494464136444401,-0.119610191352758,0.0742197501334474,0.646248363201144
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30170.Nucleated red blood cell count,47793,-0.139056083283984,0.190294784831476,-0.512033861553677,0.233921694985709,0.464945081487002
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30180.Lymphocyte percentage,47793,0.00927461854902999,0.00181614529550131,0.00571497376984742,0.0128342633282126,3.30305144530817e-07
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30190.Monocyte percentage,47793,0.000435515500800522,0.00184582851942449,-0.00318230839727148,0.00405333939887252,0.81347679235716
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30200.Neutrophill percentage,47793,-0.00613372983990172,0.00180269112816565,-0.0096670044511064,-0.00260045522869704,0.000668744704489823
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30210.Eosinophill percentage,47793,-0.00771227354300432,0.00179078550241351,-0.0112222131277348,-0.00420233395827384,1.66427276354221e-05
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30220.Basophill percentage,47793,0.000580611153892182,0.00171826647927673,-0.0027871911454902,0.00394841345327457,0.735437678392913
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30230.Nucleated red blood cell percentage,47793,-0.133455602719173,0.190239937110963,-0.506325879456661,0.239414674018315,0.482990529884975
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30240.Reticulocyte percentage,47388,0.000374376556892209,0.00189083403140051,-0.00333165814465279,0.00408041125843721,0.843050369245298
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30250.Reticulocyte count,47388,0.00221985198853849,0.00195400863881869,-0.00161000494354614,0.00604970892062311,0.255947407555046
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30260.Mean reticulocyte volume,47388,0.00849801344539676,0.00180570745259495,0.00495882683831065,0.0120372000524829,2.53854365406164e-06
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30270.Mean sphered cell volume,47388,0.0172711439594572,0.00182338827942189,0.0136973029317903,0.0208449849871241,3.00209763912613e-21
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30280.Immature reticulocyte fraction,47388,0.00193413173666077,0.00191305849537506,-0.00181546291427435,0.0056837263875959,0.312019690185818
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30290.High light scatter reticulocyte percentage,47388,0.00130137847014526,0.00194352980196527,-0.00250793994170666,0.00511069688199718,0.503122535244332
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30300.High light scatter reticulocyte count,47388,0.00280810636535953,0.0019927421352,-0.00109766821963247,0.00671388095035153,0.158799363950877
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30500.Microalbumin in urine,31171,-0.00859045191534889,0.00359641459731459,-0.0156394245260855,-0.00154147930461229,0.01693942542175
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30510.Creatinine (enzymatic) in urine,47871,-0.0063411617881774,0.00189583657559925,-0.0100570014763519,-0.00262532210000287,0.000824762531687462
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30520.Potassium in urine,47826,0.00119067304372724,0.0017610158194985,-0.00226091796248981,0.00464226404994429,0.49896573164182
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30530.Sodium in urine,47801,-0.00295929522982734,0.00185686907246888,-0.00659875861186634,0.00068016815221167,0.111016419097208
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30600.Albumin,45383,0.0313346827634959,0.00193982423980554,0.0275326272534771,0.0351367382735148,2.42387159799063e-58
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30610.Alkaline phosphatase,47448,-0.00119192321054741,0.00185262501865429,-0.00482306824710982,0.002439221826015,0.519990512052009
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30620.Alanine aminotransferase,47456,0.0110147037391689,0.00192825132942948,0.00723533113348711,0.0147940763448507,1.12850229362354e-08
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30630.Apolipoprotein A,45181,0.083100954702885,0.00207487833718567,0.0790341931620011,0.0871677162437689,0
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30640.Apolipoprotein B,47353,0.0138291811824223,0.00183747694996089,0.010227726360499,0.0174306360043456,5.41721591915986e-14
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30650.Aspartate aminotransferase,47388,0.00902286964358194,0.00186084414505641,0.00537561511927137,0.0126701241678925,1.2502081633777e-06
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30660.Direct bilirubin,42316,-0.00327133902731377,0.00209033313422606,-0.00736839197039684,0.000825713915769299,0.117604248558377
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30670.Urea,47445,0.00216821244830397,0.00193605497608337,-0.00162645530481943,0.00596288020142737,0.262762687351137
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30680.Calcium,45386,0.0242100146400041,0.00186935455308736,0.0205460797159529,0.0278739495640554,3.25220056242573e-38
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30690.Cholesterol,47456,0.0398998739706281,0.00187813521614849,0.0362187289469771,0.0435810189942792,3.33414404214202e-99
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30700.Creatinine,47451,-0.0125536498586599,0.0021447208222917,-0.0167573026703516,-0.00834999704696816,4.88515937745446e-09
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30710.C-reactive protein,47395,-0.0097950311850502,0.00201638920679642,-0.0137471540303712,-0.00584290833972921,1.19534692280064e-06
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30720.Cystatin C,47454,-0.031149565417203,0.00207906977507139,-0.0352245421763429,-0.027074588658063,1.65564169768404e-50
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30730.Gamma glutamyltransferase,47452,0.0145903061383392,0.00189804332245293,0.0108701412263314,0.0183104710503469,1.56610472005218e-14
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30740.Glucose,45362,0.000248107445606309,0.00202886360770156,-0.00372846522548874,0.00422468011670136,0.902671418507708
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30750.Glycated haemoglobin (HbA1c),47378,-0.0125180115410922,0.00204914115923268,-0.0165343282131883,-0.00850169486899617,1.01931512517216e-09
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30760.HDL cholesterol,45373,0.0895133671554312,0.00217392133303572,0.0852524813426812,0.0937742529681812,0
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30770.IGF-1,47327,0.0183091119271811,0.00185112198574089,0.014680912835129,0.0219373110192333,5.0751665037362e-23
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30780.LDL direct,47405,0.0205861749860629,0.00184020747744721,0.0169793683302663,0.0241929816418594,5.61904557754605e-29
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30790.Lipoprotein A,42866,0.000911882356886958,0.00200730808845154,-0.00302244149647807,0.00484620621025198,0.649631789494011
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30810.Phosphate,45344,-0.00167688214305076,0.00202390692958695,-0.00564373972504117,0.00228997543893966,0.407375812100697
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30830.SHBG,45147,0.000858912100685932,0.00212925940515616,-0.00331443633342015,0.00503226053479201,0.68666891247195
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30840.Total bilirubin,47372,0.00980603847026439,0.00186205002194413,0.0061564204272539,0.0134556565132749,1.4048727495806e-07
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30850.Testosterone,43496,0.0064027968646293,0.00327168112040165,-9.69813135792523e-06,0.0128152918606165,0.050357855442795
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30860.Total protein,45381,0.0194898763702223,0.00190363024445987,0.015758761091081,0.0232209916493637,1.52658189596952e-24
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30870.Triglycerides,47449,-0.0200265884006097,0.00205004590070673,-0.0240446783659949,-0.0160084984352245,1.69426730747485e-22
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30880.Urate,47423,0.00362747701833147,0.00227350043256682,-0.000828583829499501,0.00808353786616244,0.110603703210173
PON1,Serum paraoxonase/arylesterase 1,Blood and urine assays,X30890.Vitamin D,46119,0.00921439645796157,0.00201847672959255,0.00525818206796018,0.013170610847963,5.02179587231877e-06
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X3137.Number of measurements made,46482,-0.117441200376227,0.0558879463783863,-0.226981575277864,-0.00790082547458934,0.0356199123090622
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X3143.Ankle spacing width,38097,-0.0169758950736648,0.00310147336407489,-0.0230547828672516,-0.010897007280078,4.49039525174178e-08
PON1,Serum paraoxonase/arylesterase 1,Physical measures,"X3144.Heel Broadband ultrasound attenuation, direct entry",38096,0.00460245242012074,0.0025208553474506,-0.000338424060882438,0.00954332890112392,0.0679097282340756
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X3146.Speed of sound through heel,38097,0.00892483961680151,0.00243023085252787,0.0041615871458469,0.0136880920877561,0.000241177898564757
PON1,Serum paraoxonase/arylesterase 1,Physical measures,"X3147.Heel quantitative ultrasound index (QUI), direct entry",38097,0.00773443476123524,0.00246138114602647,0.00291012771502336,0.0125587418074471,0.00167976281486318
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X3148.Heel bone mineral density (BMD),38095,0.00791266939448314,0.00245513097189281,0.00310061268957323,0.0127247260993931,0.00127192952211297
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X3526.Mother's age at death,38839,0.00255235226375626,0.00237360737091846,-0.00209991818324392,0.00720462271075643,0.282256157383717
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X3581.Age at menopause (last menstrual period),38289,0.00760052324451586,0.00235678354425788,0.00298122749777041,0.0122198189912613,0.00126284557256959
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,"X3761.Age hay fever, rhinitis or eczema diagnosed",29437,0.00124463883866384,0.00396957248326895,-0.0065357232285433,0.00902500090587099,0.753879902756504
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X4100.Ankle spacing width (left),32316,-0.00857556874029683,0.0042760267166015,-0.0169565811048358,-0.000194556375757894,0.0449438890604847
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X4101.Heel broadband ultrasound attenuation (left),32315,-0.00119451576585398,0.00346897693561085,-0.00799371055965125,0.00560467902794329,0.730598026500844
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X4103.Speed of sound through heel (left),32316,0.00390294102772675,0.00338017347740135,-0.0027221989879799,0.0105280810434334,0.24826599274386
PON1,Serum paraoxonase/arylesterase 1,Physical measures,"X4104.Heel quantitative ultrasound index (QUI), direct entry (left)",32316,0.00215987643947373,0.00340941119335707,-0.00452256949950612,0.00884232237845359,0.526422837677806
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X4105.Heel bone mineral density (BMD) (left),32314,0.00231140446065243,0.00340039160969595,-0.00435336309435164,0.0089761720156565,0.496684969616399
PON1,Serum paraoxonase/arylesterase 1,Physical measures,"X4106.Heel bone mineral density (BMD) T-score, automated (left)",32316,0.00216332913018435,0.00340919377117001,-0.00451869066130886,0.00884534892167757,0.525735579590781
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X4119.Ankle spacing width (right),32317,-0.00585597391439121,0.00420455978345777,-0.0140969110899684,0.00238496326118602,0.163729499015051
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X4120.Heel broadband ultrasound attenuation (right),32317,0.00173942337358764,0.00345908561884008,-0.00504038443933891,0.0085192311865142,0.615079310754866
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X4122.Speed of sound through heel (right),32317,0.00676014144108796,0.00338044516090262,0.000134468925718819,0.0133858139564571,0.04555852173185
PON1,Serum paraoxonase/arylesterase 1,Physical measures,"X4123.Heel quantitative ultrasound index (QUI), direct entry (right)",32317,0.0051289230273509,0.00340484734975486,-0.00154457777816862,0.0118024238328704,0.132015156506452
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X4124.Heel bone mineral density (BMD) (right),32314,0.00505649934201901,0.00339929426401612,-0.00160611741545258,0.0117191160994906,0.136919093094299
PON1,Serum paraoxonase/arylesterase 1,Physical measures,"X4125.Heel bone mineral density (BMD) T-score, automated (right)",32317,0.00512942561158612,0.00340484585748235,-0.00154407226907928,0.0118029234922515,0.131977119789596
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X4194.Pulse rate,32557,0.0037771347713228,0.00336641601609412,-0.00282104062022168,0.0103753101628673,0.261893657159549
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X4195.Pulse wave reflection index,32557,-0.0015527595657273,0.00334017243384608,-0.00809949753606562,0.00499397840461101,0.64203412618721
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X4196.Pulse wave peak to peak time,32555,0.0015695238310247,0.00304458365641255,-0.00439786013554389,0.00753690779759329,0.606208335774776
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X4198.Position of the pulse wave peak,32557,0.00335741271691918,0.00295149270384815,-0.00242751298262319,0.00914233841646155,0.255350244274257
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X4199.Position of pulse wave notch,32557,0.000391895573367219,0.00329807327990861,-0.00607232805525366,0.0068561192019881,0.905416462389887
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X4200.Position of the shoulder on the pulse waveform,32557,-0.000618881065297117,0.0029443855210566,-0.00638987668656805,0.00515211455597382,0.833524489203103
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X4269.Number of triplets attempted (left),32465,-0.0501674712553405,0.22841353540476,-0.497858000648669,0.397523058137988,0.826161497538415
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X4270.Volume level set by participant (left),32381,-0.0437197166232784,0.0733675612605168,-0.187520136693891,0.100080703447334,0.551259168597866
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X4276.Number of triplets attempted (right),32467,0.0953352334787688,0.215592534402566,-0.327226133950261,0.517896600907799,0.658355716074436
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X4277.Volume level set by participant (right),32369,-0.0470155557125648,0.0748887261234204,-0.193797458914469,0.0997663474893391,0.530149463211853
PON1,Serum paraoxonase/arylesterase 1,Cognitive function,X4288.Time to answer,32616,-0.00516714870614196,0.00377821170663787,-0.0125724436511522,0.00223814623886826,0.171469460542835
PON1,Serum paraoxonase/arylesterase 1,Cognitive function,X4290.Duration screen displayed,32616,0.00167541166381102,0.00331954175626437,-0.00483089017846716,0.00818171350608919,0.613774943113567
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X46.Hand grip strength (left),48535,0.0166990940336321,0.00266891407113045,0.0114680224542165,0.0219301656130478,3.99349696257035e-10
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X47.Hand grip strength (right),48538,0.0165067076995159,0.00266670878027535,0.0112799584901763,0.0217334569088556,6.11670015073553e-10
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X48.Waist circumference,48613,-0.00775294057610271,0.00356662636287684,-0.0147435282473413,-0.000762352904864107,0.0297338759841635
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X4803.Tinnitus,32462,-0.119603262170374,0.0883245148769321,-0.292719311329161,0.053512786988413,0.175731724258368
PON1,Serum paraoxonase/arylesterase 1,Working and living environment,X4825.Noisy workplace,32595,-0.226419498418845,0.120267752068844,-0.462144292473779,0.00930529563608845,0.0597863601409374
PON1,Serum paraoxonase/arylesterase 1,Working and living environment,X4836.Loud music exposure frequency,32541,-0.166991325474857,0.138464927169502,-0.438382582727081,0.104399931777368,0.22784546764959
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X49.Hip circumference,48611,0.00868326142702594,0.00302433136737445,0.00275557194697202,0.0146109509070799,0.00409357183919511
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X50.Standing height,48608,-0.00593862629939258,0.00247644768795481,-0.010792463767784,-0.00108478883100115,0.0164905016420942
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X5057.Number of older siblings,31654,-0.131774339217603,0.0789833104203503,-0.28658162764149,0.0230329492062832,0.095283379918435
PON1,Serum paraoxonase/arylesterase 1,Physical measures,X51.Seated height,48499,-0.0039308283720534,0.00247989434327281,-0.00879142128486811,0.000929764540761313,0.112961542301225
PON1,Serum paraoxonase/arylesterase 1,Eye measures,X5181.Ever had eye surgery,29957,-0.143587679905982,0.173325290094454,-0.483305248491111,0.196129888679148,0.407463571056302
PON1,Serum paraoxonase/arylesterase 1,Eye measures,X5186.Duration visual-acuity screen displayed (right),29944,0.00255916254568835,0.00379218464506061,-0.00487351935863044,0.00999184445000714,0.499798348828987
PON1,Serum paraoxonase/arylesterase 1,Eye measures,X5188.Duration visual-acuity screen displayed (left),29944,0.00284022806781484,0.00378387025200961,-0.004576157626124,0.0102566137617537,0.45291681926588
PON1,Serum paraoxonase/arylesterase 1,Eye measures,X5190.Duration at which refractometer first shown (right),29876,0.00255665865078782,0.00382284616301402,-0.00493611982871965,0.0100494371302953,0.503661685603348
PON1,Serum paraoxonase/arylesterase 1,Eye measures,X5193.Duration at which refractometer first shown (left),29875,0.00368157315833549,0.00384447294151108,-0.00385359380702623,0.0112167401236972,0.338293296827552
PON1,Serum paraoxonase/arylesterase 1,Eye measures,"X5199.logMAR, initial (right)",29926,-0.198028397460782,0.097665660986447,-0.389453092994218,-0.00660370192734569,0.0426478747420221
PON1,Serum paraoxonase/arylesterase 1,Eye measures,X5200.Final number of letters displayed (right),29926,-0.251346349522885,0.76813129169901,-1.75688368125294,1.25419098220717,0.743515559102567
PON1,Serum paraoxonase/arylesterase 1,Eye measures,"X5201.logMAR, final (right)",29882,-0.00991377021743865,0.0039561757786226,-0.0176678747435389,-0.00215966569133835,0.01224313336419
PON1,Serum paraoxonase/arylesterase 1,Eye measures,X5202.Number of rounds to result (right),29926,0.0548772900270587,0.0888923564106245,-0.119351728537765,0.229106308591883,0.537032637066817
PON1,Serum paraoxonase/arylesterase 1,Eye measures,"X5206.logMAR, initial (left)",29924,-0.32121613682781,0.098079113763519,-0.513451199804307,-0.128981073851313,0.00106292557541609
PON1,Serum paraoxonase/arylesterase 1,Eye measures,X5207.Final number of letters displayed (left),29924,-0.312790433533341,0.606751527632415,-1.50202342769288,0.876442560626193,0.606212965092714
PON1,Serum paraoxonase/arylesterase 1,Eye measures,"X5208.logMAR, final (left)",29869,-0.00984055864355056,0.00385283383627392,-0.0173921129626474,-0.00228900432445367,0.0106731136801571
PON1,Serum paraoxonase/arylesterase 1,Eye measures,X5209.Number of rounds to result (left),29922,-0.227830607261591,0.0896094030874677,-0.403465037313028,-0.0521961772101544,0.0110341034370737
PON1,Serum paraoxonase/arylesterase 1,Eye measures,"X5254.Intra-ocular pressure, corneal-compensated (right)",29668,0.00777386586995894,0.00390920247728772,0.000111829014475004,0.0154359027254429,0.0467968106857861
PON1,Serum paraoxonase/arylesterase 1,Eye measures,"X5255.Intra-ocular pressure, Goldmann-correlated (right)",29668,0.00743316515037368,0.00393258885989694,-0.000274709015024331,0.0151410393157717,0.0587938932417545
PON1,Serum paraoxonase/arylesterase 1,Eye measures,X5256.Corneal hysteresis (right),29668,-0.00470196640749093,0.00388702821540548,-0.0123205417096857,0.0029166088947038,0.226465800211402
PON1,Serum paraoxonase/arylesterase 1,Eye measures,X5257.Corneal resistance factor (right),29668,0.000520316364888411,0.00388646666978861,-0.00709715830789726,0.00813779103767408,0.893503402271836
PON1,Serum paraoxonase/arylesterase 1,Eye measures,"X5262.Intra-ocular pressure, corneal-compensated (left)",29662,0.00903424901514181,0.00393114814174622,0.00132919865731922,0.0167392993729644,0.0215944005798781
PON1,Serum paraoxonase/arylesterase 1,Eye measures,"X5263.Intra-ocular pressure, Goldmann-correlated (left)",29662,0.00651092268320385,0.00389304087610566,-0.00111943743396325,0.0141412828003709,0.0944953348305401
PON1,Serum paraoxonase/arylesterase 1,Eye measures,X5264.Corneal hysteresis (left),29662,-0.00774111490254081,0.00397539438476111,-0.0155328878966726,5.06580915909582e-05,0.0515575757378349
PON1,Serum paraoxonase/arylesterase 1,Eye measures,X5265.Corneal resistance factor (left),29662,-0.00229030483069635,0.00392566247939309,-0.0099846032903068,0.00540399362891411,0.559636737856033
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X5364.Average weekly intake of other alcoholic drinks,29271,-0.251558952254402,0.366617239377125,-0.970128741433566,0.467010836924762,0.492643744531722
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,"X6144#1.Never eat eggs, dairy, wheat, sugar_Eggs or foods containing eggs",48534,-0.030294477559287,0.0102750066812737,-0.0504334906545834,-0.0101554644639905,0.00319765570489144
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,"X6144#2.Never eat eggs, dairy, wheat, sugar_Dairy products",48534,-0.0381603548644477,0.0107182682324814,-0.0591681606001113,-0.0171525491287841,0.000371131083655966
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,"X6144#3.Never eat eggs, dairy, wheat, sugar_Wheat products",48534,0.0112733571741435,0.0281841243456142,-0.0439675265432604,0.0665142408915474,0.689167710119465
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,"X6144#4.Never eat eggs, dairy, wheat, sugar_Sugar or foods or drinks containing sugar",48534,0.00595412808043315,0.00451196459233411,-0.00288932252054171,0.014797578681408,0.18697081212627
PON1,Serum paraoxonase/arylesterase 1,Diet and food preferences,"X6144#5.Never eat eggs, dairy, wheat, sugar_I eat all of the above",48534,0.00390356625822593,0.00412763654858239,-0.00418660137699556,0.0119937338934474,0.344303648561561
PON1,Serum paraoxonase/arylesterase 1,Mental health,"X6145#3.Illness, injury, bereavement, stress in last 2 years_Death of a close relative",35581,0.00261718164832016,0.00526866856683293,-0.00770940874267238,0.0129437720393127,0.619379114089321
PON1,Serum paraoxonase/arylesterase 1,Mental health,"X6145#4.Illness, injury, bereavement, stress in last 2 years_Death of a spouse or partner",35581,-0.00263043327022632,0.0130149988189573,-0.0281398309553826,0.02287896441493,0.839836114821543
PON1,Serum paraoxonase/arylesterase 1,Mental health,"X6145#5.Illness, injury, bereavement, stress in last 2 years_Marital separation or divorce",35581,0.0122154630648875,0.0103297561161178,-0.00803085892270342,0.0324617850524784,0.237012419325404
PON1,Serum paraoxonase/arylesterase 1,Mental health,"X6145#6.Illness, injury, bereavement, stress in last 2 years_Financial difficulties",35581,-0.00907276180682574,0.00633640642487235,-0.0214921183995755,0.00334659478592406,0.152215819179226
PON1,Serum paraoxonase/arylesterase 1,Eye measures,X6147#1.Reason for glasses or contact lenses_For short-sightedness,48605,-0.00250608355768368,0.00841379082480151,-0.0189971135742946,0.0139849464589273,0.765816950665129
PON1,Serum paraoxonase/arylesterase 1,Eye measures,X6147#2.Reason for glasses or contact lenses_For long-sightedness,48605,-0.00250608355768368,0.00841379082480151,-0.0189971135742946,0.0139849464589273,0.765816950665129
PON1,Serum paraoxonase/arylesterase 1,Eye measures,X6147#3.Reason for glasses or contact lenses_For just reading or near work as you are getting older (called 'presbyopia'),48605,0.00728641570138147,0.00682209730148565,-0.0060848950095304,0.0206577264122933,0.285503695412028
PON1,Serum paraoxonase/arylesterase 1,Eye measures,X6147#4.Reason for glasses or contact lenses_For 'astigmatism',48605,0.00679216077764358,0.0105242457703305,-0.0138353609322041,0.0274196824874913,0.518685672976827
PON1,Serum paraoxonase/arylesterase 1,Eye measures,X6147#5.Reason for glasses or contact lenses_For a 'squint' or 'turn' in an eye since childhood (called 'strabismus'),48605,-0.0588790105514805,0.0268683932111475,-0.11154106124533,-0.00621695985763136,0.0284334148237446
PON1,Serum paraoxonase/arylesterase 1,Eye measures,X6147#6.Reason for glasses or contact lenses_For a 'lazy' eye or an eye with poor vision since childhood (called 'amblyopia'),48605,-0.0221435255947747,0.018503529084077,-0.0584104425995657,0.0141233914100163,0.231427828805988
PON1,Serum paraoxonase/arylesterase 1,Eye measures,X6147#7.Reason for glasses or contact lenses_Other eye condition,48605,-0.0103585815506744,0.028919037366432,-0.0670398947888811,0.0463227316875322,0.720202409025763
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6149#1.Mouth or teeth dental problems_Mouth ulcers,48534,-0.00442792963053982,0.00547807028877723,-0.0151649473965432,0.00630908813546356,0.418925318026092
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6149#2.Mouth or teeth dental problems_Painful gums,48534,-0.0219519034215148,0.00915813421534407,-0.0399018464835892,-0.00400196035944043,0.0165382076515075
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6149#3.Mouth or teeth dental problems_Bleeding gums,48534,0.00496947084428668,0.00487309641138059,-0.00458179812201928,0.0145207398105926,0.307844555368879
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6149#4.Mouth or teeth dental problems_Loose teeth,48534,-0.000142873896713541,0.00896158856304772,-0.0177075874802871,0.01742183968686,0.987280060569855
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6149#5.Mouth or teeth dental problems_Toothache,48534,-0.0110208314091858,0.00880632726182622,-0.0282812328423652,0.00623957002399362,0.210776159523174
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6149#6.Mouth or teeth dental problems_Dentures,48534,-0.021412700671021,0.00489703975855434,-0.0310108985977875,-0.0118145027442544,1.23301127250579e-05
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6150#1.Vascular or heart problems diagnosed by doctor_Heart attack,30883,-0.0961424175983909,0.0192231542876018,-0.13381980000209,-0.0584650351946914,5.84289481686549e-07
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6150#2.Vascular or heart problems diagnosed by doctor_Angina,30883,-0.0150026455122457,0.0125653269932795,-0.0396306864190735,0.00962539539458206,0.232533055710708
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6150#3.Vascular or heart problems diagnosed by doctor_Stroke,30883,-0.0647841566714297,0.0158404539942714,-0.0958314465002016,-0.0337368668426578,4.37029918690438e-05
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6150#4.Vascular or heart problems diagnosed by doctor_High blood pressure,30883,0.0424942354988576,0.0141133257901859,0.0148321169500933,0.0701563540476219,0.00261460509576429
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6151#1.Fractured bone site(s)_Ankle,48522,0.0318149262492366,0.0133459438907919,0.00565687622328451,0.0579729762751887,0.0171395969652554
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6151#2.Fractured bone site(s)_Leg,48522,-0.0204436872638476,0.0233709482214805,-0.0662507457779494,0.0253633712502542,0.381719833268404
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6151#3.Fractured bone site(s)_Hip,48522,-0.0354758270979267,0.0374446590999122,-0.108867358933755,0.0379157047379013,0.343434203790159
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6151#4.Fractured bone site(s)_Spine,48522,0.0204884238051933,0.035442885834244,-0.0489796324299249,0.0899564800403115,0.56322312931703
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6151#5.Fractured bone site(s)_Wrist,48522,-0.00894679647387086,0.0112164958601968,-0.0309311283598566,0.0130375354121149,0.425083640567945
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6151#6.Fractured bone site(s)_Arm,48522,-0.00721729042935485,0.0160792151643354,-0.0387325521514523,0.0242979712927426,0.653537864172203
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6151#7.Fractured bone site(s)_Other bones,48522,-0.0250672782489274,0.00791920854652562,-0.0405889270001177,-0.00954562949773722,0.00155075226061083
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,"X6152#5.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the leg (DVT)",32728,-0.00688686811469547,0.0118940243899224,-0.0301991559189433,0.0164254196895523,0.562591997446802
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,"X6152#6.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Emphysema or chronic bronchitis",32728,-0.0291405338263331,0.0136955742849542,-0.0559838594248434,-0.00229720822782283,0.0333886506076494
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,"X6152#7.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the lung",32728,-0.00846071214097225,0.0178215241700175,-0.0433908995142066,0.0264694752322621,0.634979960289628
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,"X6152#8.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Asthma",32728,-0.013287828560785,0.00618787013088384,-0.0254160540173174,-0.00115960310425271,0.0317904555929209
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,"X6154#1.Medication for pain relief, constipation, heartburn_Aspirin",35794,-0.0158885226725698,0.0064140394317919,-0.028460039958882,-0.00331700538625771,0.0132581724212866
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,"X6154#2.Medication for pain relief, constipation, heartburn_Ibuprofen",35794,0.0222496686649528,0.00558402228156854,0.0113049849930785,0.0331943523368271,6.80385781883023e-05
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,"X6154#3.Medication for pain relief, constipation, heartburn_Paracetamol",35794,-0.00581574457430431,0.00524915105190158,-0.0161040806360314,0.00447259148742279,0.26791121061463
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,"X6154#4.Medication for pain relief, constipation, heartburn_Ranitidine",35794,-0.00875676560147948,0.012516871777934,-0.0332898342862301,0.0157763030832711,0.484193381169203
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,"X6154#5.Medication for pain relief, constipation, heartburn_Omeprazole",35794,-0.00939383592078816,0.00751220926915033,-0.0241177660883228,0.00533009424674648,0.211151585971938
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,"X6154#6.Medication for pain relief, constipation, heartburn_Laxatives",35794,-0.00101715783267227,0.00877463172290232,-0.0182154360095608,0.0161811203442163,0.907717769149902
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6155#1.Vitamin and mineral supplements_Vitamin A,48534,0.00157062652488169,0.0120570333797421,-0.0220611588994128,0.0252024119491762,0.896356737873583
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6155#2.Vitamin and mineral supplements_Vitamin B,48534,-0.00396665564419998,0.00765121556170067,-0.0189630381451333,0.0110297268567333,0.604159772661388
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6155#3.Vitamin and mineral supplements_Vitamin C,48534,-0.00848949057280605,0.0312003828157733,-0.0696422408917217,0.0526632597461097,0.785550754356115
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6155#4.Vitamin and mineral supplements_Vitamin D,48534,-0.00507497153087695,0.00756906531349925,-0.0199103395453355,0.00976039648358158,0.502552840894236
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6155#5.Vitamin and mineral supplements_Vitamin E,48534,-0.00793216349222063,0.00904457200385511,-0.0256595246197767,0.00979519763533539,0.380490951936115
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6155#6.Vitamin and mineral supplements_Folic acid or Folate (Vit B9),48534,-0.0375123282593676,0.0101492631687435,-0.057404884070105,-0.0176197724486303,0.000219452893681678
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6155#7.Vitamin and mineral supplements_Multivitamins + or - minerals,48534,0.00483804879196586,0.00361824179381536,-0.00225370512391225,0.011929802707844,0.181193815267022
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X6157#1.Why stopped smoking_Illness or ill health,28262,-0.0302655356304495,0.0124327085928838,-0.0546336444725018,-0.00589742678839726,0.014964272795514
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X6157#2.Why stopped smoking_Doctor's advice,28262,-0.0277644734463242,0.0166430132222955,-0.0603847793620233,0.00485583246937494,0.0953510408405389
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X6157#3.Why stopped smoking_Health precaution,28262,0.0168404606446041,0.0109763327431323,-0.00467315153193529,0.0383540728211435,0.125050673742176
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X6157#4.Why stopped smoking_Financial reasons,28262,-0.00522667763973162,0.00983781817851084,-0.0245088012696129,0.0140554459901496,0.59525279532958
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6159#1.Pain type(s) experienced in last month_Headache,48641,-0.0150575317289587,0.00412982614985347,-0.0231519909826715,-0.00696307247524589,0.000266865701883008
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6159#2.Pain type(s) experienced in last month_Facial pain,48641,-0.0192350950583413,0.0111433164175509,-0.0410759952367411,0.00260580512005852,0.0843322407661736
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6159#3.Pain type(s) experienced in last month_Neck or shoulder pain,48641,-0.00592872847428066,0.00404199115188923,-0.0138510311319835,0.00199357418342222,0.142447788528793
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6159#4.Pain type(s) experienced in last month_Back pain,48641,-0.00665749111654761,0.00402688192966855,-0.014550179698698,0.00123519746560274,0.0982905176645208
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6159#5.Pain type(s) experienced in last month_Stomach or abdominal pain,48641,-0.0153360052373083,0.00580189464499648,-0.0267077187415014,-0.00396429173311523,0.0082161150893663
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6159#6.Pain type(s) experienced in last month_Hip pain,48641,-0.00649918222347895,0.00513281992245393,-0.0165595092714887,0.00356114482453076,0.205453288049342
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6159#7.Pain type(s) experienced in last month_Knee pain,48641,-0.0119299513871522,0.00430987052121547,-0.0203772976087345,-0.00348260516556989,0.0056435116968813
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6159#8.Pain type(s) experienced in last month_Pain all over the body,48641,-0.0470638084452564,0.0116852346939314,-0.069966868445362,-0.0241607484451507,5.65137063137444e-05
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X6160#1.Leisure or social activities_Sports club or gym,41130,0.0187227854191407,0.00427923569302478,0.0103354834608121,0.0271100873774693,1.22021895699635e-05
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X6160#2.Leisure or social activities_Pub or social club,41130,0.0111904753686838,0.0047346681021066,0.00191052588855484,0.0204704248488127,0.0181137267677187
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X6160#3.Leisure or social activities_Religious group,41130,-0.0230027796648104,0.00475669024479324,-0.0323258925446052,-0.0136796667850157,1.33740687157794e-06
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X6160#4.Leisure or social activities_Adult education class,41130,-0.00270235993276683,0.0060639183575825,-0.0145876399136285,0.00918292004809487,0.655858884021031
PON1,Serum paraoxonase/arylesterase 1,Lifestyle factors,X6160#5.Leisure or social activities_Other group activity,41130,-0.00603180652020888,0.0043127828578982,-0.0144848609216894,0.00242124788127161,0.161955149499725
PON1,Serum paraoxonase/arylesterase 1,Physical activities,X6162#1.Types of transport used (excluding work)_Car or motor vehicle,48430,0.0143990792912133,0.00434070073802253,0.00589130584468911,0.0229068527377374,0.0009105166550407
PON1,Serum paraoxonase/arylesterase 1,Physical activities,X6162#2.Types of transport used (excluding work)_Walk,48430,0.00250390507271119,0.0035082464214765,-0.00437225791338275,0.00938006805880513,0.475407382741325
PON1,Serum paraoxonase/arylesterase 1,Physical activities,X6162#3.Types of transport used (excluding work)_Public transport,48430,-0.00575737621173642,0.00383248489500673,-0.0132690466059496,0.00175429418247678,0.13304398851891
PON1,Serum paraoxonase/arylesterase 1,Physical activities,X6162#4.Types of transport used (excluding work)_Cycle,48430,-0.0128542436152905,0.0084585519378094,-0.029433005413397,0.00372451818281591,0.128606050218403
PON1,Serum paraoxonase/arylesterase 1,Physical activities,X6164#1.Types of physical activity in last 4 weeks_Walking for pleasure (not as a means of transport),48441,0.0153217058396363,0.00396128690204333,0.00755758351163134,0.0230858281676412,0.000110084216568668
PON1,Serum paraoxonase/arylesterase 1,Physical activities,X6164#3.Types of physical activity in last 4 weeks_Strenuous sports,48441,0.015561095623038,0.00716619413161435,0.00151535512507389,0.0296068361210021,0.029906272197803
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6179#1.Mineral and other dietary supplements_Fish oil (including cod liver oil),48534,0.0116323079210464,0.00377961772967437,0.00422425717088461,0.0190403586712081,0.00208880140473702
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6179#2.Mineral and other dietary supplements_Glucosamine,48534,0.0119236858722051,0.00428899806120013,0.00351724967225284,0.0203301220721574,0.00543904817401497
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6179#3.Mineral and other dietary supplements_Calcium,48534,-0.00401389414853587,0.00560603405703313,-0.0150017209003208,0.00697393260324908,0.474001181140323
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6179#4.Mineral and other dietary supplements_Zinc,48534,-0.00541250728860981,0.00817769845216748,-0.0214407962548581,0.0106157816776385,0.508066044311556
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6179#5.Mineral and other dietary supplements_Iron,48534,-0.0235981762712124,0.00833787796042073,-0.039940417073637,-0.00725593546878775,0.00465519352390886
PON1,Serum paraoxonase/arylesterase 1,Health and medical history,X6179#6.Mineral and other dietary supplements_Selenium,48534,-0.000365428973499549,0.0109111265883717,-0.021751237086708,0.0210203791397089,0.973282996350678
PON1,Serum paraoxonase/arylesterase 1,Physical measures,"X78.Heel bone mineral density (BMD) T-score, automated",38097,0.00773412656418738,0.00246137621937656,0.00290982917420932,0.0125584239541654,0.00168044477186777
PON1,Serum paraoxonase/arylesterase 1,Physical activities,X864.Number of days or week walked 10+ minutes,48091,0.131069637029703,0.0441745145443638,0.0444875885227504,0.217651685536656,0.00300936636225061
PON1,Serum paraoxonase/arylesterase 1,Physical activities,X874.Duration of walks,44521,0.00510650792169215,0.00194917038958594,0.0012861339581037,0.00892688188528059,0.00880381169565611
PON1,Serum paraoxonase/arylesterase 1,Physical activities,X884.Number of days or week of moderate physical activity 10+ minutes,47145,0.057365489791275,0.0430886706636229,-0.027088304709426,0.141819284291976,0.183091921062269
PON1,Serum paraoxonase/arylesterase 1,Physical activities,X894.Duration of moderate activity,41767,-0.00285290703737977,0.0531464297336108,-0.107019909315257,0.101314095240497,0.957190636552775
PON1,Serum paraoxonase/arylesterase 1,Physical activities,X90087.No-wear time bias adjusted average acceleration,29569,0.00631728247533208,0.00390710459138513,-0.00134064252378277,0.0139752074744469,0.105967860547724
PON1,Serum paraoxonase/arylesterase 1,Physical activities,X904.Number of days or week of vigorous physical activity 10+ minutes,47170,0.177815069614572,0.0449166233906459,0.0897784877689058,0.265851651460238,7.55626728923586e-05
PON1,Serum paraoxonase/arylesterase 1,Physical activities,X914.Duration of vigorous activity,36383,0.00237155120069571,0.00255045272493183,-0.00262733614017068,0.0073704385415621,0.352464981205666
